Ultrasonic surgical instruments

Information

  • Patent Grant
  • 9636135
  • Patent Number
    9,636,135
  • Date Filed
    Monday, November 10, 2014
    10 years ago
  • Date Issued
    Tuesday, May 2, 2017
    7 years ago
Abstract
An ultrasonic surgical blade comprising a body having a proximal end and a distal end. The distal end of the body is movable relative to a longitudinal axis by vibrations produced by a transducer. The body comprises a longitudinally extending bore formed within the ultrasonic surgical blade. The ultrasonic surgical blade is configured to emit a spray from the bore at the distal end thereof to substantially prevent fluid from contacting the distal end of the ultrasonic surgical blade.
Description
BACKGROUND

The subject application is related to commonly-owned U.S. patent application Ser. No. 11/881,636, filed on Jul. 27, 2007, now U.S. Pat. No. 8,348,967, the disclosure of which is hereby incorporated by reference in its entirety, the application being respectively entitled ULTRASONIC SURGICAL INSTRUMENTS.


Ultrasonic instruments, including both hollow core and solid core instruments, are used for the safe and effective treatment of many medical conditions. Ultrasonic instruments, and particularly solid core ultrasonic instruments, are advantageous because they may be used to cut and/or coagulate tissue using energy in the form of mechanical vibrations transmitted to a surgical end effector at ultrasonic frequencies. Ultrasonic vibrations, when transmitted to organic tissue at suitable energy levels and using a suitable end effector, may be used to cut, dissect, or coagulate tissue or elevate or separate muscle tissue off bone. Ultrasonic instruments utilizing solid core technology are particularly advantageous because of the amount of ultrasonic energy that may be transmitted from the ultrasonic transducer, through an ultrasonic transmission waveguide, to the surgical end effector. Such instruments may be used for open procedures or minimally invasive procedures, such as endoscopic or laparoscopic procedures, wherein the end effector is passed through a trocar to reach the surgical site.


Activating or exciting the single or multiple element end effector (e.g., cutting blade, ball coagulator) of such instruments at ultrasonic frequencies induces longitudinal, transverse, or torsional vibratory movement that generates localized heat within adjacent tissue, facilitating both cutting and coagulating. Because of the nature of ultrasonic instruments, a particular ultrasonically actuated end effector may be designed to perform numerous functions, including, for example, cutting and coagulating.


Ultrasonic vibration is induced in the surgical end effector by electrically exciting a transducer, for example. The transducer may be constructed of one or more piezoelectric or magnetostrictive elements in the instrument hand piece. Vibrations generated by the transducer section are transmitted to the surgical end effector via an ultrasonic waveguide extending from the transducer section to the surgical end effector. The waveguides and end effectors are most preferably designed to resonate at the same frequency as the transducer. When an end effector is attached to a transducer the overall system frequency may be the same frequency as the transducer itself.


The transducer and the end effector may be designed to resonate at two different frequencies and when joined or coupled may resonate at a third frequency. The zero-to-peak amplitude of the longitudinal ultrasonic vibration at the tip, d, of the end effector behaves as a simple sinusoid at the resonant frequency as given by:

d=A sin(ωt)

where:


ω=the radian frequency which equals 2π times the cyclic frequency, f; and


A=the zero-to-peak amplitude.


The longitudinal excursion is defined as the peak-to-peak (p-t-p) amplitude, which is just twice the amplitude of the sine wave or 2 A.


Solid core ultrasonic surgical instruments may be divided into two types, single element end effector devices and multiple-element end effectors. Single element end effector devices include instruments such as scalpels (e.g., blades, sharp hook blades, dissecting hook blades, curved blades) and ball coagulators. Single-element end effector instruments have limited ability to apply blade-to-tissue pressure when the tissue is soft and loosely supported. Substantial pressure may be necessary to effectively couple ultrasonic energy to the tissue. The inability of a single-element end effector to grasp the tissue results in a further inability to fully coapt tissue surfaces while applying ultrasonic energy, leading to less-than-desired hemostasis and tissue joining. The use of multiple-element end effectors such as clamping coagulators includes a mechanism to press tissue against an ultrasonic blade that can overcome these deficiencies.


Ultrasonic clamp coagulators or clamped coagulating shears provide an improved ultrasonic surgical instrument for cutting/coagulating tissue, particularly loose and unsupported tissue, wherein the ultrasonic blade is employed in conjunction with a clamp for applying a compressive or biasing force to the tissue, whereby faster coagulation and cutting of the tissue.


As the distal end of the end effector, or more particularly, the blade, cuts through or coagulates tissue it comes into contact with fluid (e.g., blood, tissue particles). When the distal end of the blade contacts this fluid, a fine mist in the form of a diverging plume of fluid particles may emanate from the distal end of the blade. This plume of mist may limit visibility at the surgical site. It would be desirable to provide an ultrasonic instrument which reduces the plume of mist emanating from the distal end of the end effector.


SUMMARY

In one general aspect, the various embodiments are directed to an ultrasonic blade with mist reducing features. The ultrasonic blade may comprise a proximal end and a distal end. The distal end of the body may be movable relative to a longitudinal axis by vibrations produced by a transducer. The body may comprise a longitudinally extending bore formed within the ultrasonic surgical blade. The ultrasonic surgical blade may be configured to emit a spray from the bore at the distal end thereof to prevent fluid from contacting the distal end of the ultrasonic surgical blade.





FIGURES

The novel features of the various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows.



FIG. 1A illustrates one embodiment of an ultrasonic system comprising a single element end effector.



FIG. 1B illustrates one embodiment of an ultrasonic system comprising a multi-element end effector.



FIG. 2 illustrates one embodiment of a connection union/joint for an ultrasonic instrument.



FIG. 3A illustrates an exploded perspective view of one embodiment of a single element end effector ultrasonic surgical instrument that may be coupled to the ultrasonic system illustrated in FIG. 1A.



FIG. 3B illustrates one embodiment of a clamp coagulator comprising a multi-element end effector as shown in FIG. 1B.



FIG. 3C illustrates a perspective view of the multi-element end effector as shown in FIGS. 1B and 3B.



FIGS. 4-6 illustrate one embodiment of an ultrasonic blade, where:



FIG. 4 is a side view of one embodiment of an ultrasonic blade;



FIG. 5 is a cross-sectional view of the ultrasonic blade taken along line 5-5 in FIG. 4; and



FIG. 6 is a perspective view of the ultrasonic blade shown in FIG. 4.



FIGS. 7-9 illustrate various embodiments of the ultrasonic blade, where:



FIG. 7 is a side view of one embodiment of an ultrasonic blade;



FIG. 8 is a cross-sectional view of the ultrasonic blade taken along line 8-8 in FIG. 7; and



FIG. 9 is a perspective view of the ultrasonic blade shown in FIG. 7.



FIGS. 10-12 illustrate one embodiment of the ultrasonic blade, where:



FIG. 10 is a side view of one embodiment of an ultrasonic blade;



FIG. 11 is a cross-sectional view of the ultrasonic blade taken along line 11-11 in FIG. 10; and



FIG. 12 is a perspective view of the ultrasonic blade shown in FIG. 10.



FIGS. 13A-B illustrate various embodiments of an ultrasonic blade, where:



FIG. 13A is a side view of an ultrasonic blade with a convex blade tip depicting a divergent plume mist; and



FIG. 13B is a detail view of the divergent jet of fluid mist.



FIGS. 14A-B illustrate various embodiments of an ultrasonic blade, where:



FIG. 14A is a side view of an ultrasonic blade with a tapered concave surface formed at a distal end of the blade depicting a convergence of the fluid leaving the blade tip; and



FIG. 14B is a detail view of the convergent jet of fluid mist.



FIGS. 15A-D illustrate various embodiments of an ultrasonic blade, where:



FIG. 15A is a side view of an ultrasonic blade with at least a portion of the ultrasonic blade coated with at least one layer of a material which may allow the fluid to form globules on the surface of the material; and



FIG. 15B is cross-sectional view of the ultrasonic blade taken along line B-B in FIG. 15A.



FIG. 15C is a detailed view of the ultrasonic blade of FIG. 15A.



FIG. 15D illustrates a contact angle between a droplet and the surface of the ultrasonic blade of FIG. 15A.



FIGS. 16-17 illustrate various embodiments of an ultrasonic blade, where:



FIG. 16 is a side view of an ultrasonic blade with portions of the blade coated with more than one material to provide an electric charge to the blade tip; and



FIG. 17 is cross-sectional view of the ultrasonic blade taken along line 17-17 in FIG. 16.



FIGS. 18-19 illustrate various embodiments of an ultrasonic blade, where:



FIG. 18 is a side view of an ultrasonic blade with a longitudinally extending bore; and



FIG. 19 is cross-sectional view of the ultrasonic blade taken along line 19-19 in FIG. 18.



FIG. 20 is a side view of an ultrasonic blade with a convex portion within a tapered concave surface thereof.



FIG. 21-22 illustrate various embodiments of an ultrasonic blade, where:



FIG. 21 is a side view of an ultrasonic blade with a tapered concave surface extending into the blade body asymmetrically.



FIG. 22 is a cross-sectional view of the ultrasonic blade taken along line 22-22 in FIG. 21.



FIG. 23 is a perspective view of an asymmetric ultrasonic blade comprising a tapered concave surface extending inwardly into the blade body.





DESCRIPTION

Before explaining the various embodiments in detail, it should be noted that the embodiments are not limited in its application or use to the details of construction and arrangement of parts illustrated in the accompanying drawings and description. The illustrative embodiments may be implemented or incorporated in other embodiments, variations and modifications, and may be practiced or carried out in various ways. For example, the surgical instruments and blade configurations disclosed below are illustrative only and not meant to limit the scope or application thereof. Furthermore, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative embodiments for the convenience of the reader and are not to limit the scope thereof.


The various embodiments relate, in general, to ultrasonic blades for use in surgical instruments and, more particularly, to ultrasonic blades comprising mist reducing features as described herein. The various embodiments relate, in general, to ultrasonic blades and instruments to improve visibility of the surgical site during surgery by reducing the mist plume created by fluid particles colliding with a distal end of an activated ultrasonic blade. Visibility of the surgical site may be improved through the mist reducing features of the ultrasonic blades which may comprise a tapered concave surface formed at the distal end of the blade, a tip coating, a lumen fluidically coupled to a spraying mechanism, a material to hold an electric charge, or any combination thereof. The term “tapered concave surface” is defined as a concave surface formed at a distal end of the blade that is tapered inwardly from its distal end to its proximal end in the direction indicated by arrow B, various embodiments of which are shown in FIGS. 4-23. A variety of different blade configurations are disclosed which may be useful for both open and laparoscopic applications.


Examples of ultrasonic surgical instruments are disclosed in U.S. Pat. Nos. 5,322,055 and 5,954,736 and in combination with ultrasonic blades and surgical instruments disclosed in U.S. Pat. Nos. 6,309,400 B2, 6,278,218 B1, 6,283,981 B1, and 6,325,811 B1, for example, are incorporated herein by reference in their entirety. These references disclose ultrasonic surgical instruments and blade configurations where a longitudinal mode of the blade is excited. Because of asymmetry or asymmetries, ultrasonic blades also may exhibit transverse and/or torsional motion where the characteristic “wavelength” of this non-longitudinal motion is generally less than that of the general longitudinal motion of the blade and its extender portion. Therefore, the wave shape of the non-longitudinal motion will present nodal positions of transverse/torsional motion along the tissue effector while the net motion of the active blade along its tissue effector is non-zero (i.e., will have at least longitudinal motion along the length extending from its distal end, an antinode of longitudinal motion, to the first nodal position of longitudinal motion that is proximal to the tissue effector portion).


Certain embodiments will now be described to provide an overall understanding of the principles of the structure, function, manufacture, and use of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those of ordinary skill in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting embodiments and that the scope of the various embodiments is defined solely by the claims. The features illustrated or described in connection with one embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the claims.



FIG. 1A illustrates one embodiment of an ultrasonic system 10 comprising a single element end effector. One embodiment of the ultrasonic system 10 comprises an ultrasonic signal generator 12 coupled to an ultrasonic transducer 14, a hand piece assembly 60 comprising a hand piece housing 16, and an ultrasonically actuatable single element end effector or ultrasonically actuatable blade 50. The ultrasonic transducer 14, which is known as a “Langevin stack”, generally includes a transduction portion 18, a first resonator portion or end-bell 20, and a second resonator portion or fore-bell 22, and ancillary components. The total construction of these components is a resonator. The ultrasonic transducer 14 is preferably an integral number of one-half system wavelengths (nλ/2; where “n” is any positive integer; e.g., n=1, 2, 3 . . . ) in length as will be described in more detail later. An acoustic assembly 24 includes the ultrasonic transducer 14, a nose cone 26, a velocity transformer 28, and a surface 30.


It will be appreciated that the terms “proximal” and “distal” are used herein with reference to a clinician gripping the hand piece assembly 60. Thus, the blade 50 is distal with respect to the more proximal hand piece assembly 60. It will be further appreciated that, for convenience and clarity, spatial terms such as “top” and “bottom” also are used herein with respect to the clinician gripping the hand piece assembly 60. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and absolute.


The distal end of the end-bell 20 is connected to the proximal end of the transduction portion 18, and the proximal end of the fore-bell 22 is connected to the distal end of the transduction portion 18. The fore-bell 22 and the end-bell 20 have a length determined by a number of variables, including the thickness of the transduction portion 18, the density and modulus of elasticity of the material used to manufacture the end-bell 20 and the fore-bell 22, and the resonant frequency of the ultrasonic transducer 14. The fore-bell 22 may be tapered inwardly from its proximal end to its distal end to amplify the ultrasonic vibration amplitude as the velocity transformer 28, or alternately may have no amplification. A suitable vibrational frequency range may be about 20 Hz to 120 kHz and a well-suited vibrational frequency range may be about 30-100 kHz. A suitable operational vibrational frequency may be approximately 55.5 kHz, for example.


Piezoelectric elements 32 may be fabricated from any suitable material, such as, for example, lead zirconate-titanate, lead meta-niobate, lead titanate, barium titanate, or other piezoelectric ceramic material. Each of positive electrodes 34, negative electrodes 36, and the piezoelectric elements 32 has a bore extending through the center. The positive and negative electrodes 34 and 36 are electrically coupled to wires 38 and 40, respectively. The wires 38 and 40 are encased within a cable 42 and electrically connectable to the ultrasonic signal generator 12 of the ultrasonic system 10.


The ultrasonic transducer 14 of the acoustic assembly 24 converts the electrical signal from the ultrasonic signal generator 12 into mechanical energy that results in primarily a standing acoustic wave of longitudinal vibratory motion of the ultrasonic transducer 14 and the end effector 50 at ultrasonic frequencies. In another embodiment, the vibratory motion of the ultrasonic transducer may act in a different direction. For example, the vibratory motion may comprise a local longitudinal component of a more complicated motion of the tip of the ultrasonic system 10. A suitable generator is available as model number GEN04, from Ethicon Endo-Surgery, Inc., Cincinnati, Ohio. When the acoustic assembly 24 is energized, a vibratory motion standing wave is generated through the acoustic assembly 24. The ultrasonic system 10 is designed to operate at a resonance such that an acoustic standing wave pattern of predetermined amplitude is produced. The amplitude of the vibratory motion at any point along the acoustic assembly 24 depends upon the location along the acoustic assembly 24 at which the vibratory motion is measured. A minimum or zero crossing in the vibratory motion standing wave is generally referred to as a node (i.e., where motion is minimal), and a local absolute value maximum or peak in the standing wave is generally referred to as an anti-node (i.e., where local motion is maximal). The distance between an anti-node and its nearest node is one-quarter wavelength (λ/4).


The wires 38 and 40 transmit an electrical signal from the ultrasonic signal generator 12 to the positive electrodes 34 and the negative electrodes 36. The piezoelectric elements 32 are energized by the electrical signal supplied from the ultrasonic signal generator 12 in response to an actuator 44, such as a foot switch, for example, to produce an acoustic standing wave in the acoustic assembly 24. The electrical signal causes disturbances in the piezoelectric elements 32 in the form of repeated small displacements resulting in large alternating compression and tension forces within the material. The repeated small displacements cause the piezoelectric elements 32 to expand and contract in a continuous manner along the axis of the voltage gradient, producing longitudinal waves of ultrasonic energy. The ultrasonic energy is transmitted through the acoustic assembly 24 to the single element end effector such as the blade 50 via a transmission component or an ultrasonic transmission waveguide 104.


In order for the acoustic assembly 24 to deliver energy to the single element end effector 50, all components of the acoustic assembly 24 must be acoustically coupled to the blade 50. The distal end of the ultrasonic transducer 14 may be acoustically coupled at the surface 30 to the proximal end of the ultrasonic transmission waveguide 104 by a threaded connection such as a stud 48.


The components of the acoustic assembly 24 are preferably acoustically tuned such that the length of any assembly is an integral number of one-half wavelengths (nλ/2), where the wavelength λ is the wavelength of a pre-selected or operating longitudinal vibration drive frequency fd of the acoustic assembly 24. It is also contemplated that the acoustic assembly 24 may incorporate any suitable arrangement of acoustic elements.


The blade 50 may have a length substantially equal to an integral multiple of one-half system wavelengths (nλ/2). A distal end 52 of the blade 50 may be disposed near an antinode in order to provide the maximum longitudinal excursion of the distal end. When the transducer assembly is energized, the distal end 52 of the blade 50 may be configured to move in the range of, for example, approximately 10 to 500 microns peak-to-peak, and preferably in the range of about 30 to 150 microns at a predetermined vibrational frequency of 55 kHz, for example.


The blade 50 may comprise features to reduce misting. For example, the blade 50 may comprise a tapered concave surface at the distal end 52, a coating formed at the distal end 52, a lumen fluidically coupled to a spraying mechanism, a material to hold an electric charge, or any combination thereof.


The blade 50 may be coupled to the ultrasonic transmission waveguide 104. The blade 50 and the ultrasonic transmission waveguide 104 as illustrated are formed as a single unit construction from a material suitable for transmission of ultrasonic energy. Examples of such materials include Ti6Al4V (an alloy of Titanium including Aluminum and Vanadium), Aluminum, Stainless Steel, or other suitable materials. Alternately, the blade 50 may be separable (and of differing composition) from the ultrasonic transmission waveguide 104, and coupled by, for example, a stud, weld, glue, quick connect, or other suitable known methods. The length of the ultrasonic transmission waveguide 104 may be substantially equal to an integral number of one-half wavelengths (nλ/2), for example. The ultrasonic transmission waveguide 104 may be preferably fabricated from a solid core shaft constructed out of material suitable to propagate ultrasonic energy efficiently, such as the titanium alloy discussed above (i.e., Ti6Al4V) or any suitable aluminum alloy, or other alloys, for example.


The ultrasonic transmission waveguide 104 comprises a longitudinally projecting attachment post 54 at a proximal end to couple to the surface 30 of the ultrasonic transmission waveguide 104 by a threaded connection such as the stud 48. In the embodiment illustrated in FIG. 1, the ultrasonic transmission waveguide 104 includes a plurality of stabilizing silicone rings or compliant supports 56 positioned at a plurality of nodes. The silicone rings 56 dampen undesirable vibration and isolate the ultrasonic energy from an outer sheath 58 assuring the flow of ultrasonic energy in a longitudinal direction to the distal end 52 of the blade 50 with maximum efficiency.


As shown in FIG. 1, the outer sheath 58 protects a user of the ultrasonic surgical instrument 10, 100 and a patient from the ultrasonic vibrations of the ultrasonic transmission waveguide 104. The sheath 58 generally includes a hub 62 and an elongated tubular member 64. The tubular member 64 is attached to the hub 62 and has an opening extending longitudinally therethrough. The sheath 58 is threaded onto the distal end of the housing 16. The ultrasonic transmission waveguide 104 extends through the opening of the tubular member 64 and the silicone rings 56 isolate the ultrasonic transmission waveguide 104 from the outer sheath 58. The outer sheath 58 may be attached to the waveguide 104 with an isolator pin 112. The hole in the waveguide 104 may occur nominally at a displacement. The waveguide 104 may screw or snap onto the hand piece assembly 60 by the stud 48. The flat portions on the hub 62 may allow the assembly to be torqued to a required level.


The hub 62 of the sheath 58 is preferably constructed from plastic and the tubular member 64 is fabricated from stainless steel. Alternatively, the ultrasonic transmission waveguide 104 may comprise polymeric material surrounding it to isolate it from outside contact.


The distal end of the ultrasonic transmission waveguide 104 may be coupled to the proximal end of the blade 50 by an internal threaded connection, preferably at or near an antinode. It is contemplated that the blade 50 may be attached to the ultrasonic transmission waveguide 104 by any suitable means, such as a welded joint or the like. Although the blade 50 may be detachable from the ultrasonic transmission waveguide 104, it is also contemplated that the single element end effector (e.g., the blade 50) and the ultrasonic transmission waveguide 104 may be formed as a single unitary piece.



FIG. 1B illustrates one embodiment of an ultrasonic system 1000 comprising a multi-element end effector. One embodiment of the ultrasonic system 1000 comprises the ultrasonic generator 12 coupled to the ultrasonic transducer 14 described with reference to FIG. 1A. The ultrasonic transducer 14 is coupled to clamped coagulating shears 1002 comprising an instrument housing 1004. The acoustic assembly 18 delivers energy to the end effector 1016 (FIG. 3B) of the multi-element end assembly 1008 of the multi-element instrument. In order for the acoustic assembly 18 to deliver energy to the multi-element end effector or multi-element end assembly 1008, all components of the acoustic assembly 18 must be acoustically coupled to the ultrasonically active portions of the clamped coagulating shears 1002. Accordingly, the distal end of the ultrasonic transducer 14 may be acoustically coupled at the surface 30 to the proximal end of the ultrasonic transmission waveguide 104 by the threaded connection stud 48.


As previously discussed with reference to the ultrasonic system 10 shown in FIG. 1A, the components of the acoustic assembly 18 are preferably acoustically tuned such that the length of any assembly is an integral number of one-half wavelengths (nλ/2), where the wavelength λ is the wavelength of a pre-selected or operating longitudinal vibration drive frequency fd of the acoustic assembly 18. The acoustic assembly 18 may incorporate any suitable arrangement of acoustic elements.



FIG. 2 illustrates one embodiment of a connection union/joint 70 for an ultrasonic instrument. The connection union/joint 70 may be formed between the attachment post 54 of the ultrasonic transmission waveguide 104 and the surface 30 of the velocity transformer 28 at the distal end of the acoustic assembly 24. The proximal end of the attachment post 54 comprises a female threaded substantially cylindrical recess 66 to receive a portion of the threaded stud 48 therein. The distal end of the velocity transformer 28 also may comprise a female threaded substantially cylindrical recess 68 to receive a portion of the threaded stud 40. The recesses 66, 68 are substantially circumferentially and longitudinally aligned. In another embodiment (not shown), the stud is an integral component of the end of the ultrasonic transducer. For example, the treaded stud and the velocity transformer may be of a single unit construction with the stud projecting from a distal surface of the velocity transformer at the distal end of the acoustic assembly. In this embodiment, the stud is not a separate component and does not require a recess in the end of the transducer.



FIG. 3A illustrates an exploded perspective view of one embodiment of a single element end effector ultrasonic surgical instrument 100. The ultrasonic surgical instrument 100 may be employed with the ultrasonic system 10 illustrated in FIG. 1A. However, as described herein, those of ordinary skill in the art will understand that the various embodiments of the ultrasonic surgical instruments disclosed herein as well as any equivalent structures thereof could conceivably be effectively used in connection with other known ultrasonic surgical instruments without departing from the scope thereof. Thus, the protection afforded to the various ultrasonic surgical blade embodiments disclosed herein should not be limited to use only in connection with the exemplary ultrasonic surgical instrument described above.


In the embodiment illustrated in FIG. 3A, the elongated transmission component is shown as the ultrasonic waveguide 104 and the end effector is shown as a single element end effector or blade 50 suitable to cut and/or coagulate tissue. The blade 50 may be symmetrical or asymmetrical.


The length of the blade 50 may be substantially equal to an integral multiple of one-half system wavelengths (nλ/2). The distal end 52 of the blade 50 may be disposed near an anti-node in order to provide the maximum longitudinal excursion of the distal end 52. When the transducer assembly is energized, the distal end 52 of the blade 50 may be configured to move in the range of, for example, approximately 10 to 500 microns peak-to-peak, and preferably in the range of about 30 to 150 microns at a predetermined vibrational frequency.


The blade 50 may be coupled to the ultrasonic transmission waveguide 104. The blade 50 and the ultrasonic transmission guide 104 as illustrated are formed as a single unit of construction from a material suitable for transmission of ultrasonic energy such as, for example, Ti6Al4V (an alloy of titanium including aluminum and vanadium), aluminum, stainless steel, other known materials, or combinations thereof. Alternately, the blade 50 may be separable (and of differing composition) from the ultrasonic transmission waveguide 104, and coupled by, for example, a stud, weld, glue, quick connect, or other suitable known methods. The length of the ultrasonic transmission waveguide 104 may be substantially equal to an integral number of one-half system wavelengths (nλ/2), for example. The ultrasonic transmission waveguide 104 also may be preferably fabricated from a solid core shaft constructed out of material that propagates ultrasonic energy efficiently, such as titanium alloy (e.g., Ti6Al4V) or an aluminum alloy, for example. The ultrasonic transmission waveguide 104 also may be fabricated from a hollow core shaft constructed out of similar materials. The ultrasonic transmission waveguide 104 also may be fabricated with a combination solid/hollow core shaft, for example, a solid core shaft with hollow cavities positioned at various locations along the length of the shaft.


In the embodiment illustrated in FIG. 3A, the ultrasonic transmission waveguide 104 is positioned within the outer sheath 58 by a mounting O-ring 108 and a sealing ring 110. In other embodiments, one or more additional dampers or support members (not shown) also may be included along the ultrasonic transmission waveguide 104. The ultrasonic transmission waveguide 104 is affixed to the outer sheath 58 by the mounting pin 112 that passes through mounting holes 114 in the outer sheath 58 and a mounting hole 116 formed in the ultrasonic transmission waveguide 104.



FIG. 3B illustrates one embodiment of the clamped coagulating shears 1002 comprising a multi-element end effector as shown in FIG. 1B. FIG. 3C illustrates a perspective view of the multi-element end effector as shown in FIGS. 1B and 3B. With reference to FIGS. 1B, 3B and 3C, the clamped coagulating shears 1002 may be preferably attached to and removed from the acoustic assembly 18 as a unit. The proximal end of the clamped coagulating shears 1002 preferably acoustically couples to the distal surface 30 of the acoustic assembly 18. The clamped coagulating shears 1002 may be coupled to the acoustic assembly 18 by any suitable means.


The clamped coagulating shears 1002 preferably includes an instrument housing 1004 and an elongated member 1006. The elongated member 1006 may be selectively rotated with respect to the instrument housing 1004. The instrument housing 1004 includes a pivoting handle portion 1028 and a fixed handle portion 1029.


An indexing mechanism (not shown) is disposed within a cavity of the instrument housing 1004. The indexing mechanism is preferably coupled or attached on an inner tube 1014 to translate movement of the pivoting handle portion 1028 to linear motion of the inner tube 1014 to open and close the multi-element end assembly 1008. When the pivoting handle portion 1028 is moved toward the fixed handle portion 1029, the indexing mechanism slide the inner tube 1014 rearward to pivot the multi-element end assembly 1008 into a closed position. The movement of the pivoting handle portion 1028 in the opposite direction slides the indexing mechanism to displace the inner tube 1014 in the opposite direction, i.e., forwardly, and hence pivot the multi-element end assembly 1008 into its open position in the direction indicated by arrow 1020 as shown in FIG. 3B.


The pivoting handle portion 1028 includes a thumb loop 1030. A pivot pin 1032 is disposed through a first hole of the pivoting handle portion 1028 to allow pivoting as shown by arrow 1034 in FIG. 3B. As the thumb loop 1030 of the pivoting handle portion 1028 is moved in the direction of arrow 1034, away from the instrument housing 1004, the inner tube 1014 slides rearward to pivot the multi-element end assembly 1008 into a closed position.


The elongated member 1006 of the clamped coagulating shears 1002 extends from the instrument housing 1004. The elongated member 1006 preferably includes an outer member or outer tube 1012, an inner member or inner tube 1014, and a transmission component or ultrasonic transmission waveguide 104.


The multi-element end effector or multi-element end assembly 1008 includes a clamp arm assembly 1018, a tissue pad 1036, and an ultrasonic blade 1016. The clamp arm assembly 1018 is pivotally mounted about a pivot pin (not shown) to rotate in the direction indicated by arrow 1038. The ultrasonic blade 1016 comprises a tapered concave surface 1040 extending inwardly into the blade body.


The ultrasonic surgical instrument 100 and the clamped coagulating shears 1002 may be sterilized by methods known in the art such as, for example, gamma radiation sterilization, Ethelyne Oxide processes, autoclaving, soaking in sterilization liquid, or other known processes. In the embodiment illustrated in FIGS. 1A and 3A, an ultrasonic transmission assembly 102 of the surgical instrument 100 includes the single element ultrasonically actuated end effector or blade 50 coupled to the ultrasonic transmission waveguide 104. The blade 50 and the ultrasonic transmission waveguide 104 are illustrated as a single unit construction from a material suitable for transmission of ultrasonic energy as previously discussed (e.g., Ti6Al4V, Aluminum, Stainless Steel, or other known materials). Alternately, the blade 50 may be separable (and of differing composition) from the ultrasonic transmission waveguide 104, and coupled by, for example, a stud, weld, glue, quick connect, or other known methods. In the embodiment illustrated in FIGS. 1B and 3B, the ultrasonic transmission assembly 1024 of the clamped coagulating shears 1002 includes the multi-element end assembly 1008 coupled to the ultrasonic transmission waveguide 104. The length of the ultrasonic transmission waveguide 104 may be substantially equal to an integral number of one-half system wavelengths (nλ/2), for example. The ultrasonic transmission waveguide 104 may be preferably fabricated from a solid core shaft constructed out of material that propagates ultrasonic energy efficiently, such as titanium alloy (i.e., Ti6Al4V) or an aluminum alloy, for example.



FIGS. 4-22 illustrate various embodiments of ultrasonic blades, which may be considered different embodiments of the single element end effector or the blade 50 or the ultrasonic blade 1016 of the multi-element end assembly 1008 and are generally well-suited for cutting, coagulating, and reshaping tissue. In addition, these blades comprise mist reducing features. The ultrasonic blades may be employed in the above-described ultrasonic systems 10, 1000. Those skilled in the art will appreciate that although the various embodiments of the ultrasonic blades 50, 1016 are well-suited for cutting, coagulating, reshaping tissue, and reducing the mist associated with the previously discussed functions, these ultrasonic blades are multifunctional and may be employed in multiple numerous applications.



FIGS. 4-6 illustrate one embodiment of an ultrasonic blade 120. The ultrasonic blade 120 is generally well-suited for cutting, coagulating, and reshaping tissue. The ultrasonic blade 120 may be employed in various other therapeutic procedures. The ultrasonic blade 120 comprises mist reducing features as described herein. FIG. 4 is a side view of one embodiment of the ultrasonic blade 120. FIG. 5 is a cross-sectional view of one embodiment of the ultrasonic blade 120 taken along line 5-5 in FIG. 4. FIG. 6 is a perspective view of one embodiment of the ultrasonic blade in FIG. 4.


In the embodiment illustrated in FIGS. 4-6, the ultrasonic blade 120 comprises a blade body 122 having a proximal end 132 and a distal end 134. As shown in the cross-sectional view of FIG. 5, the body 122 may have a substantially circular cross section. The blade body 122 may extend along a longitudinal central axis 127. The blade body 122 may comprise a tapered concave surface 121 at the distal end 134 of the blade body 122 which may extend inwardly into the blade body 122. This inward extension may occur such that the blade body has an inwardly tapered concave shaped tip as opposed to a conventional convex shaped tip that extends outwardly or a flat faced tip. The blade body 122 may comprise a substantially elongated treatment region 128 and a neck or transition portion 130 that protrudes from the proximal end 132 of the treatment region 128. The neck portion 130 may be configured to attach to the ultrasonic transmission waveguide 104 by a stud, weld, glue, quick connect, or other suitable attachment methods, for example. In various other embodiments, the ultrasonic blade 120 and the ultrasonic transmission waveguide 104 may be formed as a single unitary body. In either configuration, the ultrasonic transmission waveguide 104 may have gain steps to amplify the mechanical vibrations transmitted to the ultrasonic blade 120 as is well known in the art. The ultrasonic blade 120 is adapted to couple to the ultrasonic transmission waveguide 104, which may be employed with the above-described ultrasonic surgical system 10.


In various embodiments, the tapered concave surface 121 may extend inwardly into the blade body 122 from a first edge 124 which may be located at the distal end 134 of the blade body 122. As previously discussed, the surface 121 may be substantially concave and may be tapered inwardly into the blade body 122. In one embodiment, as illustrated in FIG. 20, the concave surface 121 may comprise a convex portion 123 or “bump” within the concave surface 121. FIG. 20 is a side view of an ultrasonic blade 720 with the convex portion 123 formed within the concave surface 121. For example, the substantially concave surface may have a convex portion 123 or “bump” extending in a direction different from the inward direction of the extension of the surface 121 (see FIG. 20, for example).


The tapered concave surface 121 may be configured to produce a substantially convergent jet 135 of fluid mist, as shown in FIGS. 14A, B, for example. FIG. 14A is a side view of an ultrasonic blade comprising a tapered concave blade tip depicting the convergent jet 135 of fluid mist emanating from the distal end of the blade 120 in direction A. FIG. 14B is a detail view of the convergent jet 135 of fluid mist. The convergent jet 135 may be produced by the tapered concave shape of distal end 134 of the blade body 122. Fluid droplets 139 that collide with the tapered concave shape of the distal end 134 of the blade body 122 will tend to converge rather than diverge as the fluid droplets 139 travel away from the distal end 134 of the blade body 122 in the direction of arrow A. Generally, when the fluid droplets 139 collide with a convex shaped blade tip, the fluid particles 139 tend to produce a substantially divergent jet of fluid mist 137, as shown in FIGS. 13A, B, for example. FIG. 13A is a side view of an ultrasonic blade 820 with a convex blade tip depicting a typical divergent jet 137 of fluid mist. FIG. 13B is a detail view of the divergent jet 137 of fluid mist. For example, when fluid particles associated with the surgical site collide with a convex shaped distal end of a blade body, the fluid mist that emanates from the distal end 134 of the blade body in direction A, tends to produce the divergent jet 137 of fluid mist, as shown in FIG. 13A. This fluid mist may limit the visibility at the surgical site. As shown in FIG. 14B, the tapered concave surface 121 may cause the fluid droplets moving in direction A to be directed towards the longitudinal axis 127 where the fluid droplets 141 may collide and coalesce, thus increasing droplet size such that the fluid droplets 141 may drop out under the influence of gravity.


With reference now back to FIGS. 4-6, in various embodiments, the distal end 134 may comprise a first edge 124. The first edge 124 may form the base from which the tapered surface 121 extends inwardly into the blade body 122 in the direction B. The first edge 124 may be formed in a variety of shapes including a circle, an ellipse, a square, a rectangle, a pentagon, a hexagon or any suitable polygon. In one embodiment, as shown in FIGS. 4-6, the tapered concave surface 121 defines a conical shape extending inwardly in direction B into the blade body 122. The conical shape may comprise a cone with an apex 126 and a circular base. In other embodiments, the base may be an ellipse, or a polygon (e.g., a pyramid) and may also comprise a right cone (e.g., where a line joining the apex to the center of the base is at a right angle to the base plane) or an oblique cone (e.g., where a line joining the apex to the center of the base is not at a right angle to the base plane). The surface may terminate at the apex 126 within the blade body 122. The conical shape of the tapered concave surface 121 may be symmetrical or asymmetrical. In the embodiment illustrated in FIGS. 4-6, the conical shape is symmetric with the apex located substantially along the longitudinal axis 127. In other embodiments, the conical shape of the tapered concave surface 121 may be asymmetric with the apex 126 located between an outer edge 159 of the blade body 122 and the longitudinal axis 127. The tapered concave surface 121 may have a second length between the first edge 124 and the apex 126. The blade body 122 may have a first length between the proximal end 132 and the distal end 134. The first length may be at least three times the second length such that vibrations produced along the blade body 122 are substantially uniform to provide substantially even distribution of energy to the tissue.


In various other embodiments, the tapered concave surface 221 of the blade body 122 may define various other symmetrical or asymmetrical shapes. In one embodiment, as shown in FIGS. 7-9, the tapered concave surface 221 may define a frusto-conical shape. FIG. 7 is a side view of another embodiment of the ultrasonic blade 220. FIG. 8 is a cross-sectional view of the ultrasonic blade 220 taken along line 8-8 in FIG. 7. FIG. 9 is a perspective view of the ultrasonic blade 220 in FIG. 7. The frusto-conical shape may extend inwardly into the blade body 122 in direction B from the first edge 124. The frusto-conical shape may comprise all of the characteristics of a cone, as defined above, but may terminate short of a hypothetical apex of the cone, in other words, the frusto-conical shape may be a shape similar to a cone but terminating in a plane 227 substantially orthogonal to the longitudinal axis 127 as opposed to a point along or near the longitudinal axis 127 found in a cone. The tapered concave surface 221 may terminate prior to reaching the hypothetical apex within the blade body 122. For example, the frusto-conical shape may be a cone with a substantially flat top as opposed to a point. In various other embodiments, the frusto-conical shape may have a rounded top or any other suitable shape for the top portion. In the embodiments illustrated in FIGS. 7-9, the frusto-conical shape of the tapered concave surface 221 is symmetric with the center 131 of the plane 227 located substantially along the longitudinal axis 127. In other embodiments, the frusto-conical shape of the tapered concave surface 221 may be asymmetric with the center 131 of the plane 227 located between an outer edge 129 of the blade body 122 and the longitudinal axis 127.


In another embodiment, as shown in FIGS. 10-12, the ultrasonic blade 320 comprises a tapered concave surface 321 defining a partial spheroid extending inwardly into the blade body 122 in the direction B. FIG. 10 is a side view of the ultrasonic blade 320. FIG. 11 is a cross-sectional view of the ultrasonic blade 320 taken along line 11-11 in FIG. 10. FIG. 12 is a perspective view of the ultrasonic blade 320 in FIG. 10. The partial spheroid may extend inwardly from the first edge 124, or base, into the blade body 122 in the direction of B. A spheroid may be formed when an ellipse or circle is rotated about an axis. For example, when a circle is rotated about its axis, a spheroid, commonly referred to in this case as a sphere, is formed. When the ellipse is rotated about its major axis a prolate spheroid is formed, and when the ellipse is rotated about its minor axis an oblate spheroid is formed. The tapered concave surface 321 may define at least one of a partial sphere, a partial prolate spheroid, or a partial oblate spheroid. The partial spheroid may be more than half of a spheroid, less than half of a spheroid, or exactly half of a spheroid (e.g., a hemispheroid). The first edge 124 may form a circle or an ellipse which has a center 133 that may be substantially aligned with the longitudinal axis 127.


In at least one embodiment, the blade may comprise a variety of shapes. For example, the blade may be curved. The blade may be curved in any direction. In addition, the blade may comprise various cross-sections. For example, the blade may comprise a square cross-section. All of these blade shapes may comprise an axis defined between the proximal end 132 and the distal end 134 of the blade.



FIG. 23 is a perspective view of an asymmetric ultrasonic blade comprising a tapered concave surface extending inwardly into the blade body. More details regarding curved or asymmetric blades are described in U.S. Pat. No. 6,283,981, which is incorporated herein by reference. As shown in FIG. 23, the ultrasonic surgical instrument 10 may comprise an ultrasonic blade 920 and a treatment region 960 that includes a curved blade designed to cut and coagulate tissue. The treatment region 960 may be curved to provide the surgeon with better access and visibility. The treatment region 960 may also comprise a tapered concave surface 921 which may provide a mist reducing feature. As illustrated in FIG. 23, the curved treatment region may be symmetrical about x,z plane, but asymmetrical about x,y plane. The tapered concave surface 921 may extend inwardly into the blade body 922 from a first edge 924 which may extend substantially parallel to the perimeter of the blade tip 923. In other embodiments, the first edge may be a different shape from the perimeter of the blade tip. For example, the first edge may form a circle when the perimeter of the blade tip forms a trapezoid. The embodiments are not limited in this context.


As previously discussed, in various embodiments, the tapered concave surface may extend inwardly into the blade body 122 in direction B from a first edge 124 either symmetrically or asymmetrically. This extension may occur at or near the longitudinal central axis 127 of the blade body 122. For example, with respect to the embodiment illustrated in FIGS. 4-6, the surface may extend symmetrically to form or define a right cone or asymmetrically to form or define an oblique cone. FIG. 21 is a side view of an ultrasonic blade 820 with a tapered concave surface 821 extending inwardly into the blade body 122 asymmetrically along direction B. FIG. 22 is a cross-sectional view of the ultrasonic blade 820 taken along line 22-22 in FIG. 21. As shown in FIG. 21, the tapered concave surface 821 extends inwardly from the distal end 134 of the blade 820 to the proximal end 132 of the blade 820 to form a substantially oblique cone. The oblique cone may be formed asymmetrically about the longitudinal axis 127. For example, the apex 826 of the oblique cone may be offset from the center of the longitudinal axis 127 or the center 143 of the geometric shape formed by the first edge 124. The surface may form any geometrical shape, which may be formed asymmetrically within the blade body.


In various embodiments, as shown in FIGS. 15A-D, at least a portion 129 of the blade body 122 may comprise a layer of material 150 to minimize the divergent jet 137 of fluid mist (FIGS. 13A, B) associated with the ultrasonic blade 420. FIG. 15A is a side view of an ultrasonic blade 420 with at least a portion 129 of the ultrasonic blade 420 comprising at least one layer of the material 150 formed thereon. FIG. 15B is cross-sectional view of the ultrasonic blade 420 taken along line 15B-15B in FIG. 15A. FIG. 15C is a detailed view of the ultrasonic blade 420 of FIG. 15A. The coated portion 129 of the blade body 122 may be located at the distal end 134 of the ultrasonic blade 420. The coated portion 129 of the blade body 122 may comprise at least one layer of a material 150 which acts to globulize fluid particles 152 when they contact the coated portion 129 of the blade body 122. To globulize refers to creating globules or forming droplets of fluid. The material 150 may have properties which cause the material 150 to repel fluid. For example, the material 150 may be hydrophobic and thus repel fluid which may include irrigation saline, interstitial fluid, blood plasma and a cell.


The globulization of the fluid may be caused by differences between the surface tension of the material 150 and the surface tension of the fluid in contact with the material 150. The material 150 may have a surface tension which is less than the surface tension of the fluid which may cause the fluid to globulize on the surface of the material 150. A fluid may form globules or “beads” on surfaces coated with a material where the surface tension of the material 150 on the surface 156 is less than the surface tension of the fluid. The formation of globules may prevent the “wetting” or formation of a layer of fluid spreading over the surface of the coated portion 129 of the blade body 122. The globules 152 may be pushed off of the blade body 122 through the vibrating motion of the end effector 50 unlike a layer of fluid which may have to be atomized from the surface thus causing a mist to form. The effects of the differences between the surface tension of the material 150 and the surface tension of the fluid may be illustrated in terms of a contact angle formed between a fluid interface and a surface.



FIG. 15D illustrates a contact angle 156 formed between a fluid interface 157 and a surface 158 of the ultrasonic blade 122 of FIG. 15A. As shown in FIG. 15D, the contact angle 156 is the angle at which the fluid interface 157 meets the surface 158 of the material 150. The contact angle 156 is specific for any given system and is determined by the interactions across the three interfaces. For clarity, the concept is illustrated with a small liquid droplet resting on a flat horizontal solid surface. On extremely hydrophilic surfaces, a water droplet will completely spread (an effective contact angle of 0°). This occurs for surfaces that have a large affinity for water (including materials that absorb water). On many hydrophilic surfaces, water droplets will exhibit contact angles of 10° to 30°, for example. On highly hydrophobic surfaces, which are incompatible with water, one may observe a large contact angle (70° to 90°). Some surfaces have water contact angles as high as 150° or even nearly 180°. On these surfaces, water droplets simply rest on the surface, without actually wetting the surface to any significant extent, for example. These surfaces are termed superhydrophobic and can be obtained on fluorinated surfaces (TEFLON®-like coatings) that have been appropriately micropatterned. The contact angle 156 thus directly provides information on the interaction energy between the surface 156 of the material 150 and the fluid.


In various embodiments, the surface 158 of the material 150 may be hydrophobic or superhydrophobic. The first material 150 may comprise any one of polytetrafluoroethylene (TEFLON®), polypropylene, polyethylene, waxes, polycaprolactone, any combination thereof, or any other suitable hydrophobic or superhydrophobic material. For example, the first material 150 may comprise at least one of a polypropylene wax hydrocarbon mixture or TEFLON®. The first material 150 may be applied to the surface through a variety of coating techniques including dipping, spraying, brushing, drying, melting, sintering, fused curing, and any other suitable method for applying hydrophobic materials. Other methods for applying hydrophobic materials may include material deposition techniques that are well known in the art. More details regarding hydrophobic and superhydrophobic materials and methods for applying those materials to a surface are described by U.S. Pat. No. 7,041,088 and U.S. Pat. No. 6,663,941, which are incorporated herein by reference.


In various other embodiments, as shown in FIGS. 16-17, at least a portion of the blade body 122 may be coated with at least two materials which may allow an electric charge to be carried by at least one of the materials. FIG. 16 is a side view of an ultrasonic blade 520 with portions of the blade body 122 coated with more than one material to provide an electric charge to the distal end 134 of the blade body 122. FIG. 17 is cross-sectional view of the ultrasonic blade 520 taken along line 17-17 in FIG. 16. At least a first portion 129 of the blade body 122 may comprise at least one layer of a first material 160. This first material 160 may contact at least a portion of a second material 162. The first material 160 may comprise a material suitable to carry an electric charge. The electric charge carried by the first material 160 may be the same as the nominal electric charge carried by the fluid. The similar electric charges may cause the portion 129 of the blade body 122 covered with the first material to repel the fluid. For example, if the first material 160 has a positive charge and the fluid has a positive charge, the fluid will be repelled by the first material 160. Accordingly, the first material 160 acts as a hydrophobic surface. The first material 160 may receive its electrical charge carried by wires from an electrical source located at or near the proximal end 132 of the blade body 122. For example, the electrical source may comprise a direct current (“DC”) electrical source (e.g., a battery). In another embodiment, the electrical source may be located in a different location. The wires may be provided within a bore formed in the ultrasonic blade 520 or maybe provided along the outside of the ultrasonic blade 520 within a channel or conduit. The misting effect may be reduced because the fluid is repelled from the surface of the first material 160. Accordingly, there is minimal fluid on the surface of the blade body 122 to be atomized by the ultrasonically activated blade 520.


At least a second portion of the blade body 122 comprises at least one layer of a second material 162. The second material 162 may comprise an electrically insulative material. The second material 162 may be located between the first material 160 and the blade body 122. The second material 162 may insulate the blade 520, and the blade body 122, from electrical charges. The second material 162 may be an electret material which may be made from silicon dioxide, fluoropolymer, polypropylene or any other suitable material. These materials may hold a constant or slow decaying charge. The first material 160 may be a metallic layer or a vapor deposited layer acting as a floating conductor wherein wires may not be required to convey a charge to the second material 162 from an electrical source.


In another embodiment, the electric charge carried by the first material 160 may be the opposite polarity as the nominal electric charge carried by the fluid. The opposite electric charges may cause the portion 129 of the blade body 122 covered with the first material to attract the fluid. For example, if the first material 160 has a negative charge and the fluid has a positive charge, the fluid will be attracted by the first material 160. Accordingly, the first material 160 acts as a hydrophilic surface. Accordingly, electric charge on the coating materials may be selected such that they exhibit opposite charges to that of the fluid to create attraction rather than repulsion between the blade body 122 and the fluid. This may enable surgical “smoke” or mist to globulize as it collects on the surface of the blade body 122. In addition, this technique may be employed to attract other materials or constituents, such as, drug molecules, fibrin, and natural adhesives to the treatment site. These other materials or constituents may be introduced in a liquid suspension. The difference in charges between the blade body 12 ad the fluid would act to concentrate these other materials or constituents in the vicinity of the distal end of the blade body 122.


In various embodiments, as shown in FIGS. 18-19, a blade 620 may comprise a bore 180 (e.g., a lumen). FIG. 18 is a side view of the ultrasonic blade 620 with a longitudinally extending bore 180. FIG. 19 is cross-sectional view of the ultrasonic blade 620 taken along line 19-19 in FIG. 18. The bore 180 may extend longitudinally along the longitudinal axis 127, or, in certain embodiments, the bore may extend in a different direction. The bore 180 may be formed within the blade 620. The ultrasonic blade 620 may be configured to emit a spray via the bore 180 in a direction indicated by arrow 640 at the distal end 134 of the blade 620. The spray may emanate from a spray source 161 located at or near the proximal end 132 of the blade 620 and travel in the flow direction 640. The flow direction 640 may be from the proximal end 132 to the distal end of the blade 620. In another embodiment, the spray source 161 may be found in other locations. The spray emanating from the distal end 134 of the blade 620 may substantially prevent fluid from contacting the distal end 134 of the blade 620. This prevention of contact may reduce the mist as a layer of fluid may not be present on the blade 620 for atomization. The spray may comprise a gas. For example, the gas may be carbon dioxide, air or some other suitable gas.


The ultrasonic blade 120 comprises a treatment region 128 that is suitable to effect tissue, such as, for example, cut, coagulate, reshape, scrape, and remove tissue. A distal end 134 of the treatment region 128 may also comprise a tip with a cutting edge. Additional cutting edges may be positioned laterally along both sides of the treatment region 128. In one embodiment, the cutting edges extend from the proximal end 132 to the distal end 134 of the treatment region 128.


The ultrasonic blades as discussed herein may be fabricated from a material suitable for transmission of ultrasonic energy such as, for example, Ti6Al4V, Aluminum, Stainless Steel, or other known materials. The ultrasonic blade may be used in a single-element end effector (e.g., a scalpel, hook, or ball coagulator) as discussed with reference to ultrasonic system 10 and FIGS. 1A, 2 and 3A, or a multiple-element end effector (e.g., a clamping coagulating shears) as discussed with reference to ultrasonic system 1000 and FIGS. 1B, 3B, and 3C, for example.


The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.


Preferably, the various embodiments described herein will be processed before surgery. First, a new or used instrument is obtained and if necessary cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK® bag. The container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility.


It is preferred that the device is sterilized. This can be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, steam.


Although various embodiments have been described herein, many modifications and variations to those embodiments may be implemented. For example, different types of end effectors may be employed. In addition, combinations of the described embodiments may be used. For example, a concave blade tip may be coated with a hydrophobic material. Also, where materials are disclosed for certain components, other materials may be used. The foregoing description and following claims are intended to cover all such modification and variations.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.

Claims
  • 1. A surgical instrument, comprising: a transducer configured to produce vibrations at a predetermined frequency;a spray source;an ultrasonic blade extending along a longitudinal axis coupled to the transducer, wherein the ultrasonic blade comprises: a body having a proximal end and a distal end, wherein the distal end is movable relative to the longitudinal axis by the vibrations produced by the transducer;an elongate tissue treatment region extending along a lateral portion of the body, wherein the elongate tissue treatment region is configured to treat target tissue laterally abutting the ultrasonic blade; anda longitudinally extending bore formed within the blade, wherein the longitudinally extending bore is fluidically coupled to the spray source, wherein the longitudinally extending bore defines an opening at the distal end of the body from which a spray from the spray source is emitted, and wherein the spray is emitted distal to and in a direction away from the target tissue and the elongate tissue treatment region along the lateral portion of the body; anda clamp arm positioned opposite to the elongate tissue treatment region.
  • 2. The surgical instrument of claim 1, wherein the spray is configured to substantially prevent fluid from contacting the distal end of the blade.
  • 3. The surgical instrument of claim 2, wherein the spray comprises a gas.
  • 4. The surgical instrument of claim 3, wherein the gas is at least one of carbon dioxide or air.
  • 5. The surgical instrument of claim 2, wherein the spray is configured to emanate from the spray source.
  • 6. The surgical instrument of claim 5, wherein the spray source is positioned at the proximal end of the body.
  • 7. The surgical instrument of claim 1, wherein the ultrasonic blade comprises a metallic electrically conductive material.
  • 8. The surgical instrument of claim 1, wherein the ultrasonic blade comprises a material selected from the group consisting of Ti6A14V, Aluminum, and Stainless Steel.
  • 9. The surgical instrument of claim 1, wherein the ultrasonic blade comprises a hydrophobic surface.
  • 10. The surgical instrument of claim 1, wherein the body comprises a substantially cylindrical cross-section.
  • 11. The surgical instrument of claim 1, wherein the ultrasonic blade further comprises an external cutting edge extending between the proximal end and the distal end of the body.
  • 12. An end effector, comprising: an ultrasonic surgical blade, wherein the ultrasonic surgical blade comprises: a body having a proximal end and a distal end, wherein the distal end is movable relative to a longitudinal axis by vibrations produced by a transducer;an elongate tissue treatment region extending along a lateral portion of the body, wherein the elongate tissue treatment region is configured to treat target tissue laterally abutting the ultrasonic blade;a longitudinally extending bore formed within the ultrasonic surgical blade, wherein the longitudinally extending bore defines an opening at the distal end of the body from which a spray is emitted; anda spraying mechanism fluidically coupled to the longitudinally extending bore;wherein the spray is emitted distal to and in a direction away from the target tissue and the elongate tissue treatment region along the lateral portion of the body, and wherein the spray is configured to substantially prevent fluid from contacting the distal end of the blade; anda clamp arm assembly, wherein the clamp arm assembly is positioned opposite to the elongate tissue treatment region.
  • 13. The end effector of claim 12, wherein the spray comprises a gas.
  • 14. The end effector of claim 13, wherein the gas is at least one of carbon dioxide or air.
  • 15. The end effector of claim 12, wherein the spray is configured to emanate from the spraying mechanism.
  • 16. The end effector of claim 12, wherein the bore extends substantially along the longitudinal axis.
  • 17. The end effector of claim 12, wherein the body of the ultrasonic surgical blade comprises a metallic electrically conductive material.
  • 18. The end effector of claim 12, wherein the body of the ultrasonic surgical blade comprises a material selected from the group consisting of Ti6A14V, Aluminum, and Stainless Steel.
  • 19. The end effector of claim 12, wherein the body of the ultrasonic surgical blade comprises a hydrophobic surface.
  • 20. The end effector of claim 12, wherein the body of the ultrasonic surgical blade comprises a substantially cylindrical cross-section.
  • 21. The end effector of claim 12, wherein the ultrasonic surgical blade further comprises an external cutting edge extending between the proximal end and the distal end of the body.
  • 22. A surgical instrument, comprising: means for generating a fluid spray;a transducer configured to produce vibrations at a predetermined frequency; andan ultrasonic blade coupled to the transducer, wherein the ultrasonic blade comprises: a body having a proximal end and a distal end, wherein the distal end is movable relative to a longitudinal axis by the vibrations produced by the transducer;an elongate tissue treatment region extending along a lateral portion of the body, wherein the elongate tissue treatment region is configured to treat target tissue laterally abutting the ultrasonic blade; anda longitudinal bore formed within the blade, wherein the longitudinal bore is fluidically coupled to the means for generating a fluid spray, wherein the longitudinal bore defines an opening at the distal end of the body from which the fluid spray is emitted, and wherein the fluid spray is emitted distal to and in a direction away from the target tissue and the elongate tissue treatment region along the lateral portion of the body; anda clamp arm positioned opposite to the elongate tissue treatment region.
  • 23. The surgical instrument of claim 22, wherein the ultrasonic blade further comprises an external cutting edge extending between the proximal end and the distal end of the body.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional application claiming priority under 35 U.S.C. §121 to U.S. patent application Ser. No. 11/881,645, entitled ULTRASONIC SURGICAL INSTRUMENTS, filed Jul. 27, 2007, now U.S. Patent Application Publication No. 2009/0030439, the entire disclosure of which is hereby incorporated by reference herein.

US Referenced Citations (1280)
Number Name Date Kind
969528 Disbrow Sep 1910 A
1570025 Young Jan 1926 A
1813902 Bovie Jul 1931 A
2188497 Calva Jan 1940 A
2442966 Wallace Jun 1948 A
2704333 Calosi et al. Mar 1955 A
2736960 Armstrong Mar 1956 A
2849788 Creek Sep 1958 A
2874470 Richards Feb 1959 A
2990616 Balamuth et al. Jul 1961 A
RE25033 Balamuth et al. Aug 1961 E
3015961 Roney Jan 1962 A
3033407 Alfons May 1962 A
3053124 Balamuth et al. Sep 1962 A
3082805 Royce Mar 1963 A
3432691 Shoh Mar 1969 A
3433226 Boyd Mar 1969 A
3489930 Shoh Jan 1970 A
3513848 Winston et al. May 1970 A
3526219 Balamuth Sep 1970 A
3554198 Tatoian et al. Jan 1971 A
3614484 Shoh Oct 1971 A
3616375 Inoue Oct 1971 A
3629726 Popescu Dec 1971 A
3636943 Balamuth Jan 1972 A
3668486 Silver Jun 1972 A
3702948 Balamuth Nov 1972 A
3776238 Peyman et al. Dec 1973 A
3805787 Banko Apr 1974 A
3809977 Balamuth et al. May 1974 A
3830098 Antonevich Aug 1974 A
3854737 Gilliam, Sr. Dec 1974 A
3862630 Balamuth Jan 1975 A
3875945 Friedman Apr 1975 A
3885438 Harris, Sr. et al. May 1975 A
3900823 Sokal et al. Aug 1975 A
3918442 Nikolaev et al. Nov 1975 A
3924335 Balamuth et al. Dec 1975 A
3946738 Newton et al. Mar 1976 A
3955859 Stella et al. May 1976 A
3956826 Perdreaux, Jr. May 1976 A
4012647 Balamuth et al. Mar 1977 A
4074719 Semm Feb 1978 A
4156187 Murry et al. May 1979 A
4167944 Banko Sep 1979 A
4188927 Harris Feb 1980 A
4200106 Douvas et al. Apr 1980 A
4203444 Bonnell et al. May 1980 A
4300083 Heiges Nov 1981 A
4302728 Nakamura Nov 1981 A
4306570 Matthews Dec 1981 A
4445063 Smith Apr 1984 A
4491132 Aikins Jan 1985 A
4494759 Kieffer Jan 1985 A
4504264 Kelman Mar 1985 A
4512344 Barber Apr 1985 A
4526571 Wuchinich Jul 1985 A
4545374 Jacobson Oct 1985 A
4574615 Bower et al. Mar 1986 A
4617927 Manes Oct 1986 A
4633119 Thompson Dec 1986 A
4634420 Spinosa et al. Jan 1987 A
4640279 Beard Feb 1987 A
4641053 Takeda Feb 1987 A
4646738 Trott Mar 1987 A
4646756 Watmough et al. Mar 1987 A
4649919 Thimsen et al. Mar 1987 A
4662068 Polonsky May 1987 A
4674502 Imonti Jun 1987 A
4708127 Abdelghani Nov 1987 A
4712722 Hood et al. Dec 1987 A
4808154 Freeman Feb 1989 A
4819635 Shapiro Apr 1989 A
4827911 Broadwin et al. May 1989 A
4832683 Idemoto et al. May 1989 A
4836186 Scholz Jun 1989 A
4838853 Parisi Jun 1989 A
4844064 Thimsen et al. Jul 1989 A
4850354 McGurk-Burleson et al. Jul 1989 A
4852578 Companion et al. Aug 1989 A
4865159 Jamison Sep 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4878493 Pasternak et al. Nov 1989 A
4881550 Kothe Nov 1989 A
4896009 Pawlowski Jan 1990 A
4903696 Stasz et al. Feb 1990 A
4915643 Samejima et al. Apr 1990 A
4922902 Wuchinich et al. May 1990 A
4965532 Sakurai Oct 1990 A
4979952 Kubota et al. Dec 1990 A
4981756 Rhandhawa Jan 1991 A
5013956 Kurozumi et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5026370 Lottick Jun 1991 A
5026387 Thomas Jun 1991 A
5042707 Taheri Aug 1991 A
5084052 Jacobs Jan 1992 A
5105117 Yamaguchi Apr 1992 A
5109819 Custer et al. May 1992 A
5112300 Ureche May 1992 A
5123903 Quaid et al. Jun 1992 A
5126618 Takahashi et al. Jun 1992 A
D327872 McMills et al. Jul 1992 S
5152762 McElhenney Oct 1992 A
5162044 Gahn et al. Nov 1992 A
5163421 Bernstein et al. Nov 1992 A
5163537 Radev Nov 1992 A
5167725 Clark et al. Dec 1992 A
5174276 Crockard Dec 1992 A
D332660 Rawson et al. Jan 1993 S
5176677 Wuchinich Jan 1993 A
5176695 Dulebohn Jan 1993 A
5184605 Grezeszykowski Feb 1993 A
5188102 Idemoto et al. Feb 1993 A
D334173 Liu et al. Mar 1993 S
5209719 Baruch et al. May 1993 A
5213569 Davis May 1993 A
5214339 Naito May 1993 A
5218529 Meyer et al. Jun 1993 A
5221282 Wuchinich Jun 1993 A
5222937 Kagawa Jun 1993 A
5226909 Evans et al. Jul 1993 A
5226910 Kajiyama et al. Jul 1993 A
5241236 Sasaki et al. Aug 1993 A
5241968 Slater Sep 1993 A
5242460 Klein et al. Sep 1993 A
5254129 Alexander Oct 1993 A
5257988 L'Esperance, Jr. Nov 1993 A
5261922 Hood Nov 1993 A
5263957 Davison Nov 1993 A
5264925 Shipp et al. Nov 1993 A
5275166 Vaitekunas et al. Jan 1994 A
5275609 Pingleton et al. Jan 1994 A
5282800 Foshee et al. Feb 1994 A
5282817 Hoogeboom et al. Feb 1994 A
5285795 Ryan et al. Feb 1994 A
5300068 Rosar et al. Apr 1994 A
5304115 Pflueger et al. Apr 1994 A
D347474 Olson May 1994 S
5307976 Olson et al. May 1994 A
5312023 Green et al. May 1994 A
5312425 Evans et al. May 1994 A
5322055 Davison et al. Jun 1994 A
5324299 Davison et al. Jun 1994 A
5326013 Green et al. Jul 1994 A
5326342 Pflueger et al. Jul 1994 A
5344420 Hilal et al. Sep 1994 A
5345937 Middleman et al. Sep 1994 A
5346502 Estabrook et al. Sep 1994 A
5353474 Good et al. Oct 1994 A
5357164 Imabayashi et al. Oct 1994 A
5357423 Weaver et al. Oct 1994 A
5359994 Krauter et al. Nov 1994 A
5366466 Christian et al. Nov 1994 A
5368557 Nita et al. Nov 1994 A
5370645 Klicek et al. Dec 1994 A
5371429 Manna Dec 1994 A
5374813 Shipp Dec 1994 A
D354564 Medema Jan 1995 S
5381067 Greenstein et al. Jan 1995 A
5387215 Fisher Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5394187 Shipp Feb 1995 A
5396266 Brimhall Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403334 Evans et al. Apr 1995 A
5408268 Shipp Apr 1995 A
D358887 Feinberg May 1995 S
5411481 Allen et al. May 1995 A
5419761 Narayanan et al. May 1995 A
5421829 Olichney et al. Jun 1995 A
5423844 Miller Jun 1995 A
5438997 Sieben et al. Aug 1995 A
5445639 Kuslich et al. Aug 1995 A
5449370 Vaitekunas Sep 1995 A
5451220 Ciervo Sep 1995 A
5456684 Schmidt et al. Oct 1995 A
5471988 Fujio et al. Dec 1995 A
5472443 Cordis et al. Dec 1995 A
5478003 Green et al. Dec 1995 A
5483501 Park et al. Jan 1996 A
5486162 Brumbach Jan 1996 A
5490860 Middle et al. Feb 1996 A
5500216 Julian et al. Mar 1996 A
5501654 Failla et al. Mar 1996 A
5505693 Mackool Apr 1996 A
5507738 Ciervo Apr 1996 A
5527331 Kresch et al. Jun 1996 A
5540693 Fisher Jul 1996 A
5558671 Yates Sep 1996 A
5562609 Brumbach Oct 1996 A
5562610 Brumbach Oct 1996 A
5562659 Morris Oct 1996 A
5573424 Poppe Nov 1996 A
5577654 Bishop Nov 1996 A
5591187 Dekel Jan 1997 A
5593414 Shipp et al. Jan 1997 A
5601601 Tal et al. Feb 1997 A
5603773 Campbell Feb 1997 A
5607436 Pratt et al. Mar 1997 A
5618304 Hart et al. Apr 1997 A
5618492 Auten et al. Apr 1997 A
5620447 Smith et al. Apr 1997 A
5626587 Bishop et al. May 1997 A
5626595 Sklar et al. May 1997 A
5628760 Knoepfler May 1997 A
5630420 Vaitekunas May 1997 A
5632717 Yoon May 1997 A
5640741 Yano Jun 1997 A
D381077 Hunt Jul 1997 S
5651780 Jackson et al. Jul 1997 A
5653713 Michelson Aug 1997 A
5669922 Hood Sep 1997 A
5674235 Parisi Oct 1997 A
5678568 Uchikubo et al. Oct 1997 A
5690269 Bolanos et al. Nov 1997 A
5694936 Fujimoto et al. Dec 1997 A
5700261 Brinkerhoff Dec 1997 A
5704534 Huitema et al. Jan 1998 A
5709680 Yates et al. Jan 1998 A
5711472 Bryan Jan 1998 A
5713896 Nardella Feb 1998 A
5715817 Stevens-Wright et al. Feb 1998 A
5717306 Shipp Feb 1998 A
5728130 Ishikawa et al. Mar 1998 A
5730752 Alden et al. Mar 1998 A
5733074 Stöck et al. Mar 1998 A
5741226 Strukel et al. Apr 1998 A
5766164 Mueller et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5792135 Madhani et al. Aug 1998 A
5792138 Shipp Aug 1998 A
5792165 Klieman et al. Aug 1998 A
5805140 Rosenberg et al. Sep 1998 A
5808396 Boukhny Sep 1998 A
5810859 DiMatteo et al. Sep 1998 A
5817084 Jensen Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5823197 Edwards Oct 1998 A
5827323 Klieman et al. Oct 1998 A
5828160 Sugishita Oct 1998 A
5833696 Whitfield et al. Nov 1998 A
5836897 Sakurai et al. Nov 1998 A
5836957 Schulz et al. Nov 1998 A
5843109 Mehta et al. Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5858018 Shipp et al. Jan 1999 A
5873873 Smith et al. Feb 1999 A
5873882 Straub et al. Feb 1999 A
5878193 Wang et al. Mar 1999 A
5879364 Bromfield et al. Mar 1999 A
5883615 Fago et al. Mar 1999 A
5893835 Witt et al. Apr 1999 A
5897523 Wright et al. Apr 1999 A
5897569 Kellogg et al. Apr 1999 A
5903607 Tailliet May 1999 A
5904681 West, Jr. May 1999 A
5906627 Spaulding May 1999 A
5906628 Miyawaki et al. May 1999 A
5911699 Anis et al. Jun 1999 A
5916229 Evans Jun 1999 A
5929846 Rosenberg et al. Jul 1999 A
5935143 Hood Aug 1999 A
5935144 Estabrook Aug 1999 A
5938633 Beaupre Aug 1999 A
5944718 Austin et al. Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5947984 Whipple Sep 1999 A
5954736 Bishop et al. Sep 1999 A
5954746 Holthaus et al. Sep 1999 A
5957882 Nita et al. Sep 1999 A
5957943 Vaitekunas Sep 1999 A
5968007 Simon et al. Oct 1999 A
5968060 Kellogg Oct 1999 A
5974342 Petrofsky Oct 1999 A
D416089 Barton et al. Nov 1999 S
5980510 Tsonton et al. Nov 1999 A
5980546 Hood Nov 1999 A
5989274 Davison et al. Nov 1999 A
5989275 Estabrook et al. Nov 1999 A
5993465 Shipp et al. Nov 1999 A
5993972 Reich et al. Nov 1999 A
5994855 Lundell et al. Nov 1999 A
6024741 Williamson, IV et al. Feb 2000 A
6024750 Mastri et al. Feb 2000 A
6027515 Cimino Feb 2000 A
6031526 Shipp Feb 2000 A
6033375 Brumbach Mar 2000 A
6033399 Gines Mar 2000 A
6036667 Manna et al. Mar 2000 A
6036707 Spaulding Mar 2000 A
6048224 Kay Apr 2000 A
6050943 Slayton et al. Apr 2000 A
6051010 DiMatteo et al. Apr 2000 A
6056735 Okada et al. May 2000 A
6063098 Houser et al. May 2000 A
6066132 Chen et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6068647 Witt et al. May 2000 A
6077285 Boukhny Jun 2000 A
6083191 Rose Jul 2000 A
6086584 Miller Jul 2000 A
6090120 Wright et al. Jul 2000 A
6096033 Tu et al. Aug 2000 A
6099542 Cohn et al. Aug 2000 A
6109500 Alli et al. Aug 2000 A
6110127 Suzuki Aug 2000 A
6113594 Savage Sep 2000 A
6117152 Huitema Sep 2000 A
6126629 Perkins Oct 2000 A
6129735 Okada et al. Oct 2000 A
6129740 Michelson Oct 2000 A
6132368 Cooper Oct 2000 A
6132427 Jones et al. Oct 2000 A
6132448 Perez et al. Oct 2000 A
6139320 Hahn Oct 2000 A
6139561 Shibata et al. Oct 2000 A
6142615 Qiu et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6147560 Erhage et al. Nov 2000 A
6152902 Christian et al. Nov 2000 A
6154198 Rosenberg Nov 2000 A
6159160 Hsei et al. Dec 2000 A
6159175 Strukel et al. Dec 2000 A
6162194 Shipp Dec 2000 A
6165150 Banko Dec 2000 A
6174310 Kirwan, Jr. Jan 2001 B1
6179853 Sachse et al. Jan 2001 B1
6183426 Akisada et al. Feb 2001 B1
6193709 Miyawaki et al. Feb 2001 B1
6204592 Hur Mar 2001 B1
6205855 Pfeiffer Mar 2001 B1
6206844 Reichel et al. Mar 2001 B1
6210337 Dunham et al. Apr 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210403 Klicek Apr 2001 B1
6214023 Whipple et al. Apr 2001 B1
6228080 Gines May 2001 B1
6231565 Tovey et al. May 2001 B1
6233476 Strommer et al. May 2001 B1
6238366 Savage et al. May 2001 B1
6245065 Panescu et al. Jun 2001 B1
6252110 Uemura et al. Jun 2001 B1
D444365 Bass et al. Jul 2001 S
D445092 Lee Jul 2001 S
D445764 Lee Jul 2001 S
6254623 Haibel, Jr. et al. Jul 2001 B1
6257241 Wampler Jul 2001 B1
6258034 Hanafy Jul 2001 B1
6267761 Ryan Jul 2001 B1
6270831 Kumar et al. Aug 2001 B2
6273852 Lehe et al. Aug 2001 B1
6274963 Estabrook et al. Aug 2001 B1
6277115 Saadat Aug 2001 B1
6278218 Madan et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6283981 Beaupre Sep 2001 B1
6287344 Wampler et al. Sep 2001 B1
6290575 Shipp Sep 2001 B1
6306157 Shchervinsky Oct 2001 B1
6309400 Beaupre Oct 2001 B2
6319221 Savage et al. Nov 2001 B1
6325795 Lindemann et al. Dec 2001 B1
6325799 Goble Dec 2001 B1
6325811 Messerly Dec 2001 B1
6328751 Beaupre Dec 2001 B1
6332891 Himes Dec 2001 B1
6338657 Harper et al. Jan 2002 B1
6340352 Okada et al. Jan 2002 B1
6350269 Shipp et al. Feb 2002 B1
6352532 Kramer et al. Mar 2002 B1
6358264 Banko Mar 2002 B2
6364888 Niemeyer et al. Apr 2002 B1
6379320 Lafon et al. Apr 2002 B1
D457958 Dycus et al. May 2002 S
6383194 Pothula May 2002 B1
6384690 Wilhelmsson et al. May 2002 B1
6387109 Davison et al. May 2002 B1
6388657 Natoli May 2002 B1
6391042 Cimino May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6402743 Orszulak et al. Jun 2002 B1
6402748 Schoenman et al. Jun 2002 B1
6405733 Fogarty et al. Jun 2002 B1
6416486 Wampler Jul 2002 B1
6423073 Bowman Jul 2002 B2
6423082 Houser et al. Jul 2002 B1
6425906 Young et al. Jul 2002 B1
6428538 Blewett et al. Aug 2002 B1
6428539 Baxter et al. Aug 2002 B1
6432118 Messerly Aug 2002 B1
6436114 Novak et al. Aug 2002 B1
6436115 Beaupre Aug 2002 B1
6440062 Ouchi Aug 2002 B1
6443968 Holthaus et al. Sep 2002 B1
6443969 Novak et al. Sep 2002 B1
6449006 Shipp Sep 2002 B1
6454781 Witt et al. Sep 2002 B1
6454782 Schwemberger Sep 2002 B1
6458142 Faller et al. Oct 2002 B1
6475215 Tanrisever Nov 2002 B1
6480796 Wiener Nov 2002 B2
6485490 Wampler et al. Nov 2002 B2
6491708 Madan et al. Dec 2002 B2
6497715 Satou Dec 2002 B2
6500176 Truckai et al. Dec 2002 B1
6500188 Harper et al. Dec 2002 B2
6500312 Wedekamp Dec 2002 B2
6506208 Hunt et al. Jan 2003 B2
6511478 Burnside et al. Jan 2003 B1
6511493 Moutafis et al. Jan 2003 B1
6514267 Jewett Feb 2003 B2
6524251 Rabiner et al. Feb 2003 B2
6524316 Nicholson et al. Feb 2003 B1
6527736 Attinger et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6537291 Friedman et al. Mar 2003 B2
6543452 Lavigne Apr 2003 B1
6543456 Freeman Apr 2003 B1
6544260 Markel et al. Apr 2003 B1
6558376 Bishop May 2003 B2
6561983 Cronin et al. May 2003 B2
6565558 Lindenmeier et al. May 2003 B1
6572563 Ouchi Jun 2003 B2
6572632 Zisterer et al. Jun 2003 B2
6575969 Rittman, III et al. Jun 2003 B1
6582427 Goble et al. Jun 2003 B1
6582451 Marucci et al. Jun 2003 B1
D477408 Bromley Jul 2003 S
6588277 Giordano et al. Jul 2003 B2
6589200 Schwemberger et al. Jul 2003 B1
6589239 Khandkar et al. Jul 2003 B2
6607540 Shipp Aug 2003 B1
6610059 West, Jr. Aug 2003 B1
6616450 Mossle et al. Sep 2003 B2
6619529 Green et al. Sep 2003 B2
6623500 Cook et al. Sep 2003 B1
6623501 Heller et al. Sep 2003 B2
6626848 Neuenfeldt Sep 2003 B2
6626926 Friedman et al. Sep 2003 B2
6629974 Penny et al. Oct 2003 B2
6633234 Wiener et al. Oct 2003 B2
6644532 Green et al. Nov 2003 B2
6652513 Panescu et al. Nov 2003 B2
6652539 Shipp et al. Nov 2003 B2
6652545 Shipp et al. Nov 2003 B2
6656132 Ouchi Dec 2003 B1
6656177 Truckai et al. Dec 2003 B2
6660017 Beaupre Dec 2003 B2
6662127 Wiener et al. Dec 2003 B2
6663941 Brown et al. Dec 2003 B2
6666860 Takahashi Dec 2003 B1
6666875 Sakurai et al. Dec 2003 B1
6669690 Okada et al. Dec 2003 B1
6669710 Moutafis et al. Dec 2003 B2
6676660 Wampler et al. Jan 2004 B2
6678621 Wiener et al. Jan 2004 B2
6679875 Honda et al. Jan 2004 B2
6679899 Wiener et al. Jan 2004 B2
6682544 Mastri et al. Jan 2004 B2
6685701 Orszulak et al. Feb 2004 B2
6685703 Pearson et al. Feb 2004 B2
6689145 Lee et al. Feb 2004 B2
6689146 Himes Feb 2004 B1
6716215 David et al. Apr 2004 B1
6719692 Kleffner et al. Apr 2004 B2
6719776 Baxter Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
D490059 Conway et al. May 2004 S
6731047 Kauf et al. May 2004 B2
6733506 McDevitt et al. May 2004 B1
6739872 Turri May 2004 B1
6740079 Eggers et al. May 2004 B1
D491666 Kimmell et al. Jun 2004 S
6743245 Lobdell Jun 2004 B2
6746284 Spink, Jr. Jun 2004 B1
6746443 Morley et al. Jun 2004 B1
6752815 Beaupre Jun 2004 B2
6755825 Shoenman et al. Jun 2004 B2
6761698 Shibata et al. Jul 2004 B2
6762535 Take et al. Jul 2004 B2
6770072 Truckai et al. Aug 2004 B1
6773409 Truckai et al. Aug 2004 B2
6773443 Truwit et al. Aug 2004 B2
6773444 Messerly Aug 2004 B2
6778023 Christensen Aug 2004 B2
6783524 Anderson et al. Aug 2004 B2
6786382 Hoffman Sep 2004 B1
6786383 Stegelmann Sep 2004 B2
6790173 Saadat et al. Sep 2004 B2
6790216 Ishikawa Sep 2004 B1
6796981 Wham et al. Sep 2004 B2
D496997 Dycus et al. Oct 2004 S
6802843 Truckai et al. Oct 2004 B2
6808525 Latterell et al. Oct 2004 B2
6809508 Donofrio Oct 2004 B2
6810281 Brock et al. Oct 2004 B2
6827712 Tovey et al. Dec 2004 B2
6828712 Battaglin et al. Dec 2004 B2
6835082 Gonnering Dec 2004 B2
6849073 Hoey et al. Feb 2005 B2
6860878 Brock Mar 2005 B2
6863676 Lee et al. Mar 2005 B2
6869439 White et al. Mar 2005 B2
6875220 Du et al. Apr 2005 B2
6877647 Green et al. Apr 2005 B2
6882439 Ishijima Apr 2005 B2
6887209 Kadziauskas et al. May 2005 B2
6887252 Okada et al. May 2005 B1
6899685 Kermode et al. May 2005 B2
6905497 Truckai et al. Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6913579 Truckai et al. Jul 2005 B2
6915623 Dey et al. Jul 2005 B2
6923804 Eggers et al. Aug 2005 B2
6926712 Phan Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6929602 Hirakui et al. Aug 2005 B2
6929632 Nita et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6933656 Matsushita et al. Aug 2005 B2
D509589 Wells Sep 2005 S
6942660 Pantera et al. Sep 2005 B2
6942677 Nita et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6946779 Birgel Sep 2005 B2
6948503 Refior et al. Sep 2005 B2
D511145 Donofrio et al. Nov 2005 S
6974450 Weber et al. Dec 2005 B2
6976844 Hickok et al. Dec 2005 B2
6976969 Messerly Dec 2005 B2
6977495 Donofrio Dec 2005 B2
6979332 Adams Dec 2005 B2
6981628 Wales Jan 2006 B2
6984220 Wuchinich Jan 2006 B2
6994708 Manzo Feb 2006 B2
7001335 Adachi et al. Feb 2006 B2
7011657 Truckai et al. Mar 2006 B2
7014638 Michelson Mar 2006 B2
7033357 Baxter et al. Apr 2006 B2
7037306 Podany May 2006 B2
7041083 Chu et al. May 2006 B2
7041088 Nawrocki et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7044949 Orszulak et al. May 2006 B2
7066893 Hibner et al. Jun 2006 B2
7066895 Podany Jun 2006 B2
7070597 Truckai et al. Jul 2006 B2
7074218 Washington et al. Jul 2006 B2
7074219 Levine et al. Jul 2006 B2
7077039 Gass et al. Jul 2006 B2
7077845 Hacker et al. Jul 2006 B2
7077853 Kramer et al. Jul 2006 B2
7083619 Truckai et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7090672 Underwood et al. Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101378 Salameh et al. Sep 2006 B2
7104834 Robinson et al. Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
D531311 Guerra et al. Oct 2006 S
7117034 Kronberg Oct 2006 B2
7118564 Ritchie et al. Oct 2006 B2
7124932 Isaacson et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7128720 Podany Oct 2006 B2
7131860 Sartor et al. Nov 2006 B2
7135018 Ryan et al. Nov 2006 B2
7135030 Schwemberger et al. Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7144403 Booth Dec 2006 B2
7153315 Miller Dec 2006 B2
D536093 Nakajima et al. Jan 2007 S
7156189 Bar-Cohen et al. Jan 2007 B1
7156853 Muratsu Jan 2007 B2
7157058 Marhasin et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7163548 Stulen et al. Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7179254 Pendekanti et al. Feb 2007 B2
7179271 Friedman et al. Feb 2007 B2
7186253 Truckai et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
D541418 Schechter et al. Apr 2007 S
7204820 Akahoshi Apr 2007 B2
7207997 Shipp et al. Apr 2007 B2
7210881 Greenberg May 2007 B2
7211079 Treat May 2007 B2
7217128 Atkin et al. May 2007 B2
7217269 El-Galley et al. May 2007 B2
7220951 Truckai et al. May 2007 B2
7223229 Inman et al. May 2007 B2
7229455 Sakurai et al. Jun 2007 B2
7235071 Gonnering Jun 2007 B2
7244262 Wiener et al. Jul 2007 B2
7258688 Shah et al. Aug 2007 B1
7269873 Brewer et al. Sep 2007 B2
7273483 Wiener et al. Sep 2007 B2
D552241 Bromley et al. Oct 2007 S
7282048 Goble et al. Oct 2007 B2
7285895 Beaupré Oct 2007 B2
7300431 Dubrovsky Nov 2007 B2
7300435 Wham et al. Nov 2007 B2
7300446 Beaupre Nov 2007 B2
7303531 Lee et al. Dec 2007 B2
7303557 Wham et al. Dec 2007 B2
7306597 Manzo Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311706 Schoenman et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7317955 McGreevy Jan 2008 B2
7318831 Alvarez et al. Jan 2008 B2
7326236 Andreas et al. Feb 2008 B2
7331410 Yong et al. Feb 2008 B2
7335165 Truwit et al. Feb 2008 B2
7335997 Wiener Feb 2008 B2
7337010 Howard et al. Feb 2008 B2
7353068 Tanaka et al. Apr 2008 B2
7354440 Truckaj et al. Apr 2008 B2
7364577 Wham et al. Apr 2008 B2
RE40388 Gines Jun 2008 E
7380695 Doll et al. Jun 2008 B2
7380696 Shelton, IV et al. Jun 2008 B2
7381209 Truckai et al. Jun 2008 B2
7390317 Taylor et al. Jun 2008 B2
7404508 Smith et al. Jul 2008 B2
7408288 Hara Aug 2008 B2
7416101 Shelton, IV et al. Aug 2008 B2
7416437 Sartor et al. Aug 2008 B2
D576725 Shumer et al. Sep 2008 S
7419490 Falkenstein et al. Sep 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7422463 Kuo Sep 2008 B2
D578643 Shumer et al. Oct 2008 S
D578644 Shumer et al. Oct 2008 S
D578645 Shumer et al. Oct 2008 S
7431704 Babaev Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7455208 Wales et al. Nov 2008 B2
7462181 Kraft et al. Dec 2008 B2
7464846 Sheltion, IV et al. Dec 2008 B2
7472815 Shelton, IV et al. Jan 2009 B2
7473263 Johnston et al. Jan 2009 B2
7479148 Beaupre Jan 2009 B2
7479160 Branch et al. Jan 2009 B2
7481775 Weikel, Jr. et al. Jan 2009 B2
7488285 Honda et al. Feb 2009 B2
7494468 Rabiner et al. Feb 2009 B2
7502234 Goliszek et al. Mar 2009 B2
7503893 Kucklick Mar 2009 B2
7503895 Rabiner et al. Mar 2009 B2
7506790 Shelton, IV Mar 2009 B2
7506791 Omaits et al. Mar 2009 B2
7524320 Tierney et al. Apr 2009 B2
7530986 Beaupre et al. May 2009 B2
7534243 Chin et al. May 2009 B1
D594983 Price et al. Jun 2009 S
7540871 Gonnering Jun 2009 B2
7544200 Houser Jun 2009 B2
7549564 Boudreaux Jun 2009 B2
7559450 Wales et al. Jul 2009 B2
7567012 Namikawa Jul 2009 B2
7569057 Liu et al. Aug 2009 B2
7572266 Young et al. Aug 2009 B2
7578820 Moore et al. Aug 2009 B2
7582084 Swanson et al. Sep 2009 B2
7582095 Shipp et al. Sep 2009 B2
7585181 Olsen Sep 2009 B2
7588176 Timm et al. Sep 2009 B2
7601119 Shahinian Oct 2009 B2
7607557 Shelton, IV et al. Oct 2009 B2
7621930 Houser Nov 2009 B2
7641653 Dalla Betta et al. Jan 2010 B2
7654431 Hueil et al. Feb 2010 B2
7659833 Warner et al. Feb 2010 B2
7665647 Shelton, IV et al. Feb 2010 B2
7670334 Hueil et al. Mar 2010 B2
7670338 Albrecht et al. Mar 2010 B2
7674263 Ryan Mar 2010 B2
7678069 Baker et al. Mar 2010 B1
7678125 Shipp Mar 2010 B2
7682366 Sakurai et al. Mar 2010 B2
7686770 Cohen Mar 2010 B2
7686826 Lee et al. Mar 2010 B2
7688028 Phillips et al. Mar 2010 B2
7691098 Wallace et al. Apr 2010 B2
7699846 Ryan Apr 2010 B2
7713202 Boukhny et al. May 2010 B2
7714481 Sakai May 2010 B2
7717312 Beetel May 2010 B2
7717915 Miyazawa May 2010 B2
D618797 Price et al. Jun 2010 S
7726537 Olson et al. Jun 2010 B2
7727177 Bayat Jun 2010 B2
7738969 Bleich Jun 2010 B2
7740594 Hibner Jun 2010 B2
7751115 Song Jul 2010 B2
D621503 Otten et al. Aug 2010 S
7766210 Shelton, IV et al. Aug 2010 B2
7766693 Sartor et al. Aug 2010 B2
7770774 Mastri et al. Aug 2010 B2
7770775 Shelton, IV et al. Aug 2010 B2
7771425 Dycus et al. Aug 2010 B2
7771444 Patel et al. Aug 2010 B2
7775972 Brock et al. Aug 2010 B2
7778733 Nowlin et al. Aug 2010 B2
7780054 Wales Aug 2010 B2
7780593 Ueno et al. Aug 2010 B2
7780651 Madhani et al. Aug 2010 B2
7780659 Okada et al. Aug 2010 B2
7784662 Wales et al. Aug 2010 B2
7796969 Kelly et al. Sep 2010 B2
7798386 Schall et al. Sep 2010 B2
7799020 Shores et al. Sep 2010 B2
7799045 Masuda Sep 2010 B2
7803152 Honda et al. Sep 2010 B2
7806891 Nowlin et al. Oct 2010 B2
7810693 Broehl et al. Oct 2010 B2
7811283 Moses et al. Oct 2010 B2
7819819 Quick et al. Oct 2010 B2
D627066 Romero Nov 2010 S
7824401 Manzo et al. Nov 2010 B2
7832611 Boyden et al. Nov 2010 B2
7834484 Sartor Nov 2010 B2
7837699 Yamada et al. Nov 2010 B2
7845537 Shelton, IV et al. Dec 2010 B2
7846155 Houser et al. Dec 2010 B2
7846161 Dumbauld et al. Dec 2010 B2
7854735 Houser et al. Dec 2010 B2
D631155 Peine et al. Jan 2011 S
7861906 Doll et al. Jan 2011 B2
7862560 Marion Jan 2011 B2
7876030 Taki et al. Jan 2011 B2
D631965 Price et al. Feb 2011 S
7878991 Babaev Feb 2011 B2
7879033 Sartor et al. Feb 2011 B2
7892606 Thies et al. Feb 2011 B2
7901400 Wham et al. Mar 2011 B2
7901423 Stulen et al. Mar 2011 B2
7905881 Masuda et al. Mar 2011 B2
7909824 Masuda et al. Mar 2011 B2
7922061 Shelton, IV et al. Apr 2011 B2
7922651 Yamada et al. Apr 2011 B2
D637288 Houghton May 2011 S
D638540 Ijiri et al. May 2011 S
7936203 Zimlich May 2011 B2
7951095 Makin et al. May 2011 B2
7951165 Golden et al. May 2011 B2
7959050 Smith et al. Jun 2011 B2
7959626 Hong et al. Jun 2011 B2
7972329 Refior et al. Jul 2011 B2
7976544 McClurken et al. Jul 2011 B2
7981050 Ritchart et al. Jul 2011 B2
7998157 Culp et al. Aug 2011 B2
8038693 Allen Oct 2011 B2
8057498 Robertson Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8061014 Smith et al. Nov 2011 B2
8070711 Bassinger et al. Dec 2011 B2
8070762 Escudero et al. Dec 2011 B2
8075558 Truckai et al. Dec 2011 B2
8089197 Rinner et al. Jan 2012 B2
8097012 Kagarise Jan 2012 B2
8105323 Buysse et al. Jan 2012 B2
8142461 Houser et al. Mar 2012 B2
8152825 Madan et al. Apr 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8161977 Shelton, IV et al. Apr 2012 B2
8162966 Connor et al. Apr 2012 B2
8172846 Brunnett et al. May 2012 B2
8172870 Shipp May 2012 B2
8177800 Spitz et al. May 2012 B2
8182502 Stulen et al. May 2012 B2
8186877 Klimovitch et al. May 2012 B2
D661801 Price et al. Jun 2012 S
D661802 Price et al. Jun 2012 S
D661803 Price et al. Jun 2012 S
D661804 Price et al. Jun 2012 S
8197472 Lau et al. Jun 2012 B2
8197502 Smith et al. Jun 2012 B2
8207651 Gilbert Jun 2012 B2
8210411 Yates et al. Jul 2012 B2
8226675 Houser et al. Jul 2012 B2
8235917 Joseph et al. Aug 2012 B2
8236019 Houser Aug 2012 B2
8236020 Smith et al. Aug 2012 B2
8241271 Millman et al. Aug 2012 B2
8246575 Viola Aug 2012 B2
8246615 Behnke Aug 2012 B2
8252012 Stulen Aug 2012 B2
8253303 Giordano et al. Aug 2012 B2
8257377 Wiener et al. Sep 2012 B2
8257387 Cunningham Sep 2012 B2
8273087 Kimura et al. Sep 2012 B2
D669992 Schafer et al. Oct 2012 S
D669993 Merchant et al. Oct 2012 S
8286846 Smith et al. Oct 2012 B2
8287485 Kimura et al. Oct 2012 B2
8287528 Wham et al. Oct 2012 B2
8287532 Carroll et al. Oct 2012 B2
8292888 Whitman Oct 2012 B2
8298223 Wham et al. Oct 2012 B2
8298225 Gilbert Oct 2012 B2
8303576 Brock Nov 2012 B2
8303580 Wham et al. Nov 2012 B2
8319400 Houser et al. Nov 2012 B2
8323302 Robertson et al. Dec 2012 B2
8333778 Smith et al. Dec 2012 B2
8333779 Smith et al. Dec 2012 B2
8334468 Palmer et al. Dec 2012 B2
8334635 Voegele et al. Dec 2012 B2
8337407 Quistgaard et al. Dec 2012 B2
8338726 Palmer et al. Dec 2012 B2
8344596 Nield et al. Jan 2013 B2
8348967 Stulen Jan 2013 B2
8357103 Mark et al. Jan 2013 B2
8366727 Witt et al. Feb 2013 B2
8372099 Deville et al. Feb 2013 B2
8372101 Smith et al. Feb 2013 B2
8372102 Stulen et al. Feb 2013 B2
8374670 Selkee Feb 2013 B2
8377059 Deville et al. Feb 2013 B2
8377085 Smith et al. Feb 2013 B2
8382748 Geisel Feb 2013 B2
8382775 Bender et al. Feb 2013 B1
8382782 Robertson et al. Feb 2013 B2
8403948 Deville et al. Mar 2013 B2
8403949 Palmer et al. Mar 2013 B2
8403950 Palmer et al. Mar 2013 B2
8418073 Mohr et al. Apr 2013 B2
8418349 Smith et al. Apr 2013 B2
8419757 Smith et al. Apr 2013 B2
8419758 Smith et al. Apr 2013 B2
8419759 Dietz Apr 2013 B2
8425545 Smith et al. Apr 2013 B2
8430898 Wiener et al. Apr 2013 B2
8435257 Smith et al. May 2013 B2
8439912 Cunningham et al. May 2013 B2
8439939 Deville et al. May 2013 B2
8444637 Podmore et al. May 2013 B2
8444662 Palmer et al. May 2013 B2
8444664 Balanev et al. May 2013 B2
8460288 Tamai et al. Jun 2013 B2
8461744 Wiener et al. Jun 2013 B2
8469981 Robertson et al. Jun 2013 B2
8479969 Shelton, IV Jul 2013 B2
8480703 Nicholas et al. Jul 2013 B2
8485413 Scheib et al. Jul 2013 B2
8486057 Behnke, II Jul 2013 B2
8486096 Robertson et al. Jul 2013 B2
8491578 Manwaring et al. Jul 2013 B2
D687549 Johnson et al. Aug 2013 S
8506555 Ruiz Morales Aug 2013 B2
8509318 Tailliet Aug 2013 B2
8512359 Whitman et al. Aug 2013 B2
8512365 Wiener et al. Aug 2013 B2
8523889 Stulen et al. Sep 2013 B2
8531064 Robertson et al. Sep 2013 B2
8535340 Allen Sep 2013 B2
8535341 Allen Sep 2013 B2
8546996 Messerly et al. Oct 2013 B2
8546999 Houser et al. Oct 2013 B2
8568400 Gilbert Oct 2013 B2
8573461 Shelton, IV et al. Nov 2013 B2
8573465 Shelton, IV Nov 2013 B2
8579928 Robertson et al. Nov 2013 B2
8591459 Clymer et al. Nov 2013 B2
8591506 Wham et al. Nov 2013 B2
8591536 Robertson Nov 2013 B2
D695407 Price et al. Dec 2013 S
D696631 Price et al. Dec 2013 S
8602031 Reis et al. Dec 2013 B2
8602288 Shelton, IV et al. Dec 2013 B2
8608745 Guzman et al. Dec 2013 B2
8616431 Timm et al. Dec 2013 B2
8623027 Price et al. Jan 2014 B2
8650728 Wan et al. Feb 2014 B2
8652155 Houser et al. Feb 2014 B2
8659208 Rose et al. Feb 2014 B1
8663220 Wiener et al. Mar 2014 B2
8690582 Rohrbach et al. Apr 2014 B2
8696366 Chen et al. Apr 2014 B2
8704425 Giordano et al. Apr 2014 B2
8709031 Stulen Apr 2014 B2
8749116 Messerly et al. Jun 2014 B2
8752749 Moore et al. Jun 2014 B2
8753338 Widenhouse et al. Jun 2014 B2
8754570 Voegele et al. Jun 2014 B2
8764735 Coe et al. Jul 2014 B2
8773001 Wiener et al. Jul 2014 B2
8779648 Giordano et al. Jul 2014 B2
8784418 Romero Jul 2014 B2
8808319 Houser et al. Aug 2014 B2
8827992 Koss et al. Sep 2014 B2
8845537 Tanaka et al. Sep 2014 B2
8882791 Stulen Nov 2014 B2
8888776 Dietz et al. Nov 2014 B2
8888809 Davison et al. Nov 2014 B2
8900259 Houser et al. Dec 2014 B2
8911460 Neurohr et al. Dec 2014 B2
8951248 Messerly et al. Feb 2015 B2
8951272 Robertson et al. Feb 2015 B2
8956349 Aldridge et al. Feb 2015 B2
8961547 Dietz et al. Feb 2015 B2
8968355 Malkowski et al. Mar 2015 B2
8974477 Yamada Mar 2015 B2
8979890 Boudreaux Mar 2015 B2
8986287 Park et al. Mar 2015 B2
8986302 Aldridge et al. Mar 2015 B2
8989903 Weir et al. Mar 2015 B2
9017326 DiNardo et al. Apr 2015 B2
9039695 Giordano et al. May 2015 B2
9044261 Houser Jun 2015 B2
9050093 Aldridge et al. Jun 2015 B2
9050124 Houser Jun 2015 B2
9060775 Wiener et al. Jun 2015 B2
9060776 Yates et al. Jun 2015 B2
9066747 Robertson Jun 2015 B2
9072539 Messerly et al. Jul 2015 B2
9089360 Messerly et al. Jul 2015 B2
9095367 Olson et al. Aug 2015 B2
9107689 Robertson et al. Aug 2015 B2
9113940 Twomey Aug 2015 B2
20010025173 Ritchie et al. Sep 2001 A1
20010025183 Shahidi et al. Sep 2001 A1
20010025184 Messerly Sep 2001 A1
20010031950 Ryan Oct 2001 A1
20010039419 Francischelli et al. Nov 2001 A1
20020002377 Cimino Jan 2002 A1
20020019649 Sikora et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020029055 Bonutti Mar 2002 A1
20020049551 Friedman et al. Apr 2002 A1
20020052617 Anis et al. May 2002 A1
20020077550 Rabiner et al. Jun 2002 A1
20020156466 Sakurai et al. Oct 2002 A1
20020156493 Houser et al. Oct 2002 A1
20030014087 Fang et al. Jan 2003 A1
20030036705 Hare et al. Feb 2003 A1
20030050572 Brautigam et al. Mar 2003 A1
20030055443 Spotnitz Mar 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030144680 Kellogg et al. Jul 2003 A1
20030199794 Sakurai et al. Oct 2003 A1
20030204199 Novak et al. Oct 2003 A1
20030212332 Fenton et al. Nov 2003 A1
20030212363 Shipp Nov 2003 A1
20030212392 Fenton et al. Nov 2003 A1
20030212422 Fenton et al. Nov 2003 A1
20030229344 Dycus et al. Dec 2003 A1
20040030254 Babaev Feb 2004 A1
20040030330 Brassell et al. Feb 2004 A1
20040047485 Sherrit et al. Mar 2004 A1
20040054364 Aranyi et al. Mar 2004 A1
20040064151 Mollenauer Apr 2004 A1
20040092921 Kadziauskas et al. May 2004 A1
20040092992 Adams et al. May 2004 A1
20040097912 Gonnering May 2004 A1
20040097919 Wellman et al. May 2004 A1
20040097996 Rabiner et al. May 2004 A1
20040116952 Sakurai et al. Jun 2004 A1
20040132383 Langford et al. Jul 2004 A1
20040147934 Kiester Jul 2004 A1
20040167508 Wham et al. Aug 2004 A1
20040176686 Hare et al. Sep 2004 A1
20040176751 Weitzner et al. Sep 2004 A1
20040199193 Hayashi et al. Oct 2004 A1
20040204728 Haefner Oct 2004 A1
20040243147 Lipow Dec 2004 A1
20040260300 Gorensek et al. Dec 2004 A1
20050021018 Anderson et al. Jan 2005 A1
20050021065 Yamada et al. Jan 2005 A1
20050033337 Muir et al. Feb 2005 A1
20050049546 Messerly et al. Mar 2005 A1
20050070800 Takahashi Mar 2005 A1
20050096683 Ellins et al. May 2005 A1
20050099824 Dowling et al. May 2005 A1
20050103819 Racenet et al. May 2005 A1
20050143769 White et al. Jun 2005 A1
20050149108 Cox Jul 2005 A1
20050165345 Laufer et al. Jul 2005 A1
20050177184 Easley Aug 2005 A1
20050182339 Lee et al. Aug 2005 A1
20050188743 Land Sep 2005 A1
20050192610 Houser et al. Sep 2005 A1
20050209620 Du et al. Sep 2005 A1
20050222598 Ho et al. Oct 2005 A1
20050234484 Houser et al. Oct 2005 A1
20050249667 Tuszynski et al. Nov 2005 A1
20050256405 Makin et al. Nov 2005 A1
20050261581 Hughes et al. Nov 2005 A1
20050261588 Makin et al. Nov 2005 A1
20050273090 Nieman et al. Dec 2005 A1
20050288659 Kimura et al. Dec 2005 A1
20060030797 Zhou et al. Feb 2006 A1
20060058825 Ogura et al. Mar 2006 A1
20060063130 Hayman et al. Mar 2006 A1
20060066181 Bromfield et al. Mar 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060079879 Faller et al. Apr 2006 A1
20060084963 Messerly Apr 2006 A1
20060095046 Trieu et al. May 2006 A1
20060190034 Nishizawa et al. Aug 2006 A1
20060206100 Eskridge et al. Sep 2006 A1
20060206115 Schomer et al. Sep 2006 A1
20060211943 Beaupre Sep 2006 A1
20060217729 Eskridge et al. Sep 2006 A1
20060235306 Cotter et al. Oct 2006 A1
20060247558 Yamada Nov 2006 A1
20060253050 Yoshimine et al. Nov 2006 A1
20060264809 Hansmann et al. Nov 2006 A1
20060271030 Francis et al. Nov 2006 A1
20070016235 Tanaka et al. Jan 2007 A1
20070016236 Beaupre Jan 2007 A1
20070055228 Berg et al. Mar 2007 A1
20070056596 Fanney et al. Mar 2007 A1
20070060915 Kucklick Mar 2007 A1
20070060935 Schwardt et al. Mar 2007 A1
20070063618 Bromfield Mar 2007 A1
20070074584 Talarico et al. Apr 2007 A1
20070088217 Babaev Apr 2007 A1
20070106317 Shelton, IV et al. May 2007 A1
20070129716 Daw et al. Jun 2007 A1
20070130771 Ehlert et al. Jun 2007 A1
20070131034 Ehlert et al. Jun 2007 A1
20070149881 Rabin Jun 2007 A1
20070162050 Sartor Jul 2007 A1
20070166663 Telles et al. Jul 2007 A1
20070173803 Wham et al. Jul 2007 A1
20070173813 Odom Jul 2007 A1
20070173872 Neuenfeldt Jul 2007 A1
20070175949 Shelton, IV et al. Aug 2007 A1
20070185380 Kucklick Aug 2007 A1
20070191712 Messerly et al. Aug 2007 A1
20070219481 Babaev Sep 2007 A1
20070239028 Houser et al. Oct 2007 A1
20070239101 Kellogg Oct 2007 A1
20070249941 Salehi et al. Oct 2007 A1
20070260234 McCullagh et al. Nov 2007 A1
20070265560 Soltani et al. Nov 2007 A1
20070275348 Lemon Nov 2007 A1
20070282335 Young et al. Dec 2007 A1
20070287933 Phan et al. Dec 2007 A1
20070288055 Lee Dec 2007 A1
20080009848 Paraschiv et al. Jan 2008 A1
20080013809 Zhu et al. Jan 2008 A1
20080051812 Schmitz et al. Feb 2008 A1
20080058585 Novak et al. Mar 2008 A1
20080058775 Darian et al. Mar 2008 A1
20080058845 Shimizu et al. Mar 2008 A1
20080077145 Boyden et al. Mar 2008 A1
20080082039 Babaev Apr 2008 A1
20080082098 Tanaka et al. Apr 2008 A1
20080114364 Goldin et al. May 2008 A1
20080125768 Tahara et al. May 2008 A1
20080140158 Hamel et al. Jun 2008 A1
20080147092 Rogge et al. Jun 2008 A1
20080171938 Masuda et al. Jul 2008 A1
20080172051 Masuda et al. Jul 2008 A1
20080177268 Daum et al. Jul 2008 A1
20080188878 Young Aug 2008 A1
20080200940 Eichmann et al. Aug 2008 A1
20080208108 Kimura Aug 2008 A1
20080208231 Ota et al. Aug 2008 A1
20080214967 Aranyi et al. Sep 2008 A1
20080234709 Houser Sep 2008 A1
20080243106 Coe et al. Oct 2008 A1
20080243162 Shibata et al. Oct 2008 A1
20080245371 Gruber Oct 2008 A1
20080249553 Gruber et al. Oct 2008 A1
20080255423 Kondo et al. Oct 2008 A1
20080262490 Williams Oct 2008 A1
20080281200 Voic et al. Nov 2008 A1
20080281315 Gines Nov 2008 A1
20080281322 Sherman et al. Nov 2008 A1
20080287948 Newton et al. Nov 2008 A1
20090023985 Ewers Jan 2009 A1
20090048537 Lydon et al. Feb 2009 A1
20090054886 Yachi et al. Feb 2009 A1
20090054894 Yachi Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090082716 Akahoshi Mar 2009 A1
20090112229 Omori et al. Apr 2009 A1
20090118751 Wiener et al. May 2009 A1
20090118802 Mioduski et al. May 2009 A1
20090138006 Bales et al. May 2009 A1
20090143799 Smith et al. Jun 2009 A1
20090143800 Deville et al. Jun 2009 A1
20090143806 Witt et al. Jun 2009 A1
20090149801 Crandall et al. Jun 2009 A1
20090163807 Sliwa Jun 2009 A1
20090207923 Dress Aug 2009 A1
20090216157 Yamada Aug 2009 A1
20090223033 Houser Sep 2009 A1
20090254077 Craig Oct 2009 A1
20090254080 Honda Oct 2009 A1
20090270771 Takahashi Oct 2009 A1
20090270812 Litscher et al. Oct 2009 A1
20090270853 Yachi et al. Oct 2009 A1
20090270899 Carusillo et al. Oct 2009 A1
20090275940 Malackowski et al. Nov 2009 A1
20090318945 Yoshimine et al. Dec 2009 A1
20090327715 Smith et al. Dec 2009 A1
20100004508 Naito et al. Jan 2010 A1
20100016785 Takuma Jan 2010 A1
20100016852 Manzo et al. Jan 2010 A1
20100022825 Yoshie Jan 2010 A1
20100030233 Whitman et al. Feb 2010 A1
20100030248 Palmer et al. Feb 2010 A1
20100036370 Mirel et al. Feb 2010 A1
20100042077 Okada Feb 2010 A1
20100049180 Wells et al. Feb 2010 A1
20100063525 Beaupre et al. Mar 2010 A1
20100063528 Beaupré Mar 2010 A1
20100069940 Miller et al. Mar 2010 A1
20100158307 Kubota et al. Jun 2010 A1
20100187283 Crainich et al. Jul 2010 A1
20100222714 Muir et al. Sep 2010 A1
20100228264 Robinson et al. Sep 2010 A1
20100234906 Koh Sep 2010 A1
20100262134 Jensen et al. Oct 2010 A1
20100274160 Yachi et al. Oct 2010 A1
20100280407 Polster Nov 2010 A1
20100292691 Brogna Nov 2010 A1
20100298743 Nield et al. Nov 2010 A1
20100298851 Nield Nov 2010 A1
20100331742 Masuda Dec 2010 A1
20110004233 Muir et al. Jan 2011 A1
20110009850 Main et al. Jan 2011 A1
20110077648 Lee et al. Mar 2011 A1
20110087218 Boudreaux et al. Apr 2011 A1
20110112526 Fritz et al. May 2011 A1
20110125151 Strauss et al. May 2011 A1
20110125174 Babaev May 2011 A1
20110144806 Sandhu et al. Jun 2011 A1
20110196399 Robertson et al. Aug 2011 A1
20110224689 Larkin et al. Sep 2011 A1
20110238065 Hunt et al. Sep 2011 A1
20110257650 Deville et al. Oct 2011 A1
20110270126 Gunday et al. Nov 2011 A1
20110290853 Shelton, IV et al. Dec 2011 A1
20110290856 Shelton, IV et al. Dec 2011 A1
20120004655 Kim et al. Jan 2012 A1
20120022525 Dietz et al. Jan 2012 A1
20120022530 Woodruff et al. Jan 2012 A1
20120022583 Sugalski et al. Jan 2012 A1
20120059289 Nield et al. Mar 2012 A1
20120065628 Naito Mar 2012 A1
20120071863 Lee et al. Mar 2012 A1
20120078139 Aldridge et al. Mar 2012 A1
20120078243 Worrell et al. Mar 2012 A1
20120078244 Worrell et al. Mar 2012 A1
20120078247 Worrell et al. Mar 2012 A1
20120078278 Bales, Jr. et al. Mar 2012 A1
20120080332 Shelton, IV et al. Apr 2012 A1
20120101495 Young et al. Apr 2012 A1
20120101501 Nishimura et al. Apr 2012 A1
20120109159 Jordan et al. May 2012 A1
20120116379 Yates et al. May 2012 A1
20120116391 Houser et al. May 2012 A1
20120116394 Timm et al. May 2012 A1
20120116395 Madan et al. May 2012 A1
20120130256 Buysse et al. May 2012 A1
20120130365 McLawhorn May 2012 A1
20120136354 Rupp May 2012 A1
20120138660 Shelton, IV Jun 2012 A1
20120143211 Kishi Jun 2012 A1
20120150170 Buysse et al. Jun 2012 A1
20120165816 Kersten et al. Jun 2012 A1
20120172873 Artale et al. Jul 2012 A1
20120172904 Muir et al. Jul 2012 A1
20120177005 Liang et al. Jul 2012 A1
20120184946 Price et al. Jul 2012 A1
20120199630 Shelton, IV Aug 2012 A1
20120199632 Spivey et al. Aug 2012 A1
20120203143 Sanai et al. Aug 2012 A1
20120203247 Shelton, IV et al. Aug 2012 A1
20120209289 Duque et al. Aug 2012 A1
20120209303 Frankhouser et al. Aug 2012 A1
20120210223 Eppolito Aug 2012 A1
20120215220 Manzo et al. Aug 2012 A1
20120245582 Kimball et al. Sep 2012 A1
20120253370 Ross et al. Oct 2012 A1
20120265196 Turner et al. Oct 2012 A1
20120269676 Houser et al. Oct 2012 A1
20120330307 Ladtkow et al. Dec 2012 A1
20130012957 Shelton, IV et al. Jan 2013 A1
20130030433 Heard Jan 2013 A1
20130035680 Ben-Haim et al. Feb 2013 A1
20130053840 Krapohl et al. Feb 2013 A1
20130072856 Frankhouser et al. Mar 2013 A1
20130072857 Frankhouser et al. Mar 2013 A1
20130079762 Twomey et al. Mar 2013 A1
20130103023 Monson et al. Apr 2013 A1
20130103024 Monson et al. Apr 2013 A1
20130110145 Weitzman May 2013 A1
20130123776 Monson et al. May 2013 A1
20130123777 Monson et al. May 2013 A1
20130123782 Trees et al. May 2013 A1
20130123822 Wellman et al. May 2013 A1
20130131660 Monson et al. May 2013 A1
20130165929 Muir et al. Jun 2013 A1
20130211397 Parihar et al. Aug 2013 A1
20130217967 Mohr et al. Aug 2013 A1
20130226207 Stulen et al. Aug 2013 A1
20130226208 Wiener et al. Aug 2013 A1
20130245659 Robertson et al. Sep 2013 A1
20130253498 Germain et al. Sep 2013 A1
20130267975 Timm et al. Oct 2013 A1
20130274734 Maass et al. Oct 2013 A1
20130282003 Messerly et al. Oct 2013 A1
20130282038 Dannaher et al. Oct 2013 A1
20130282039 Wiener et al. Oct 2013 A1
20130285758 Aldridge et al. Oct 2013 A1
20130289591 Boudreaux et al. Oct 2013 A1
20130296908 Schulte et al. Nov 2013 A1
20130338661 Behnke, II Dec 2013 A1
20130345689 Ruddenklau et al. Dec 2013 A1
20140005640 Shelton, IV et al. Jan 2014 A1
20140005653 Shelton, IV et al. Jan 2014 A1
20140005654 Batross et al. Jan 2014 A1
20140005656 Mucilli et al. Jan 2014 A1
20140005661 Shelton, IV et al. Jan 2014 A1
20140005662 Shelton, IV et al. Jan 2014 A1
20140005667 Stulen et al. Jan 2014 A1
20140005668 Rhee et al. Jan 2014 A1
20140005676 Shelton, IV et al. Jan 2014 A1
20140005680 Shelton, IV et al. Jan 2014 A1
20140005681 Gee et al. Jan 2014 A1
20140005682 Worrell et al. Jan 2014 A1
20140005701 Olson et al. Jan 2014 A1
20140005702 Timm et al. Jan 2014 A1
20140005703 Stulen et al. Jan 2014 A1
20140005704 Vakharia et al. Jan 2014 A1
20140005705 Weir et al. Jan 2014 A1
20140005708 Shelton, IV et al. Jan 2014 A1
20140005718 Shelton, IV et al. Jan 2014 A1
20140012299 Stoddard et al. Jan 2014 A1
20140066962 Robertson et al. Mar 2014 A1
20140087569 Lee Mar 2014 A1
20140107538 Wiener et al. Apr 2014 A1
20140114327 Boudreaux et al. Apr 2014 A1
20140135804 Weisenburgh, II et al. May 2014 A1
20140155921 Price et al. Jun 2014 A1
20140180280 Sigmon, Jr. Jun 2014 A1
20140243864 Voegele et al. Aug 2014 A1
20140276738 Price et al. Sep 2014 A1
20140276970 Messerly et al. Sep 2014 A1
20140336686 Houser et al. Nov 2014 A1
20150045819 Houser et al. Feb 2015 A1
20150073460 Stulen Mar 2015 A1
20150112335 Boudreaux et al. Apr 2015 A1
20150119914 Neurohr et al. Apr 2015 A1
20150119915 Neurohr et al. Apr 2015 A1
20150119916 Dietz et al. Apr 2015 A1
20150123348 Robertson et al. May 2015 A1
20150157355 Price et al. Jun 2015 A1
20150157356 Gee Jun 2015 A1
20150164533 Felder et al. Jun 2015 A1
20150164534 Felder et al. Jun 2015 A1
20150164535 Felder et al. Jun 2015 A1
20150164536 Czarnecki et al. Jun 2015 A1
20150164537 Cagle et al. Jun 2015 A1
20150164538 Aldridge et al. Jun 2015 A1
20150182251 Messerly et al. Jul 2015 A1
20150182276 Wiener et al. Jul 2015 A1
20150182277 Wiener et al. Jul 2015 A1
20150196318 Messerly et al. Jul 2015 A1
20150250495 Robertson et al. Sep 2015 A1
20150257780 Houser Sep 2015 A1
20150257781 Houser et al. Sep 2015 A1
20150265308 Houser et al. Sep 2015 A1
20150282834 Robertson Oct 2015 A1
Foreign Referenced Citations (273)
Number Date Country
2003241752 Sep 2003 AU
2535467 Apr 1993 CA
1233944 Nov 1999 CN
1253485 May 2000 CN
1634601 Jul 2005 CN
1640365 Jul 2005 CN
1694649 Nov 2005 CN
1922563 Feb 2007 CN
1951333 Apr 2007 CN
101040799 Sep 2007 CN
101467917 Jan 2009 CN
3904558 Aug 1990 DE
9210327 Nov 1992 DE
4323585 Jan 1995 DE
19608716 Apr 1997 DE
20021619 Mar 2001 DE
10042606 Aug 2001 DE
0136855 Sep 1984 EP
0171967 Feb 1986 EP
1839599 Oct 1987 EP
0336742 Apr 1989 EP
0342448 Nov 1989 EP
0424685 May 1991 EP
0443256 Aug 1991 EP
0456470 Nov 1991 EP
0238667 Feb 1993 EP
0598976 Jan 1994 EP
0677275 Mar 1995 EP
0482195 Jan 1996 EP
0695535 Feb 1996 EP
0741996 Nov 1996 EP
0612570 Jun 1997 EP
1108394 Jun 2001 EP
1138264 Oct 2001 EP
0908148 Jan 2002 EP
1229515 Aug 2002 EP
1285634 Feb 2003 EP
0908155 Jun 2003 EP
0705570 Apr 2004 EP
0765637 Jul 2004 EP
0870473 Sep 2005 EP
0624346 Nov 2005 EP
1594209 Nov 2005 EP
1199044 Dec 2005 EP
1609428 Dec 2005 EP
1199043 Mar 2006 EP
1433425 Jun 2006 EP
1256323 Sep 2006 EP
1698289 Sep 2006 EP
1704824 Sep 2006 EP
1749479 Feb 2007 EP
1815950 Aug 2007 EP
1844720 Oct 2007 EP
1862133 Dec 2007 EP
1875875 Jan 2008 EP
1199045 Jun 2008 EP
1964530 Sep 2008 EP
1972264 Sep 2008 EP
1974771 Oct 2008 EP
1435852 Dec 2008 EP
1498082 Dec 2008 EP
1707131 Dec 2008 EP
1997438 Dec 2008 EP
1477104 Jan 2009 EP
2014218 Jan 2009 EP
2042112 Apr 2009 EP
1832259 Jun 2009 EP
2074959 Jul 2009 EP
2106758 Oct 2009 EP
2111813 Oct 2009 EP
2200145 Jun 2010 EP
1214913 Jul 2010 EP
2238938 Oct 2010 EP
2298154 Mar 2011 EP
1510178 Jun 2011 EP
2305144 Jun 2011 EP
2335630 Jun 2011 EP
1502551 Jul 2011 EP
2361562 Aug 2011 EP
2365608 Sep 2011 EP
2420197 Feb 2012 EP
2422721 Feb 2012 EP
1927321 Apr 2012 EP
2510891 Oct 2012 EP
2316359 Mar 2013 EP
1586275 May 2013 EP
1616529 Sep 2013 EP
2583633 Oct 2014 EP
1482943 Aug 1977 GB
2032221 Apr 1980 GB
2379878 Nov 2004 GB
2447767 Aug 2011 GB
5208761 Jun 2013 JO
S 50-100891 Dec 1973 JP
S 59-68512 Oct 1983 JP
S 59141938 Aug 1984 JP
62-221343 Sep 1987 JP
S 62-227343 Oct 1987 JP
62-292153 Dec 1987 JP
S 62-292154 Dec 1987 JP
63-109386 May 1988 JP
63-315049 Dec 1988 JP
H 01-151452 Jun 1989 JP
H 01-198540 Aug 1989 JP
02-71510 May 1990 JP
2-286149 Nov 1990 JP
H 02-292193 Dec 1990 JP
H 03-37061 Feb 1991 JP
04-25707 Feb 1992 JP
H 04-64351 Feb 1992 JP
4-30508 Mar 1992 JP
H 04-150847 May 1992 JP
H 04-152942 May 1992 JP
05-095955 Apr 1993 JP
H 05-115490 May 1993 JP
H 06-070938 Mar 1994 JP
6-104503 Apr 1994 JP
6-507081 Aug 1994 JP
H 06-217988 Aug 1994 JP
H 7-508910 Oct 1995 JP
7-308323 Nov 1995 JP
8-24266 Jan 1996 JP
8-275951 Oct 1996 JP
H 08-299351 Nov 1996 JP
H 08-336545 Dec 1996 JP
H 09-503146 Mar 1997 JP
H 09-135553 May 1997 JP
H 09-135563 May 1997 JP
H 09-140722 Jun 1997 JP
H 10-005237 Jan 1998 JP
10-295700 Nov 1998 JP
H 11-501543 Feb 1999 JP
H 11-128238 May 1999 JP
H 11-192235 Jul 1999 JP
11-253451 Sep 1999 JP
H 11-318918 Nov 1999 JP
2000-041991 Feb 2000 JP
2000-070279 Mar 2000 JP
2000-210299 Aug 2000 JP
2000-287987 Oct 2000 JP
2001-029353 Feb 2001 JP
2001-502216 Feb 2001 JP
2003612 Jun 2001 JP
2001-309925 Nov 2001 JP
2002-186901 Jul 2002 JP
2002-204808 Jul 2002 JP
2002-263579 Sep 2002 JP
2002-301086 Oct 2002 JP
2002-330977 Nov 2002 JP
2002-542690 Dec 2002 JP
2003-000612 Jan 2003 JP
2003-010201 Jan 2003 JP
2003-510158 Mar 2003 JP
2003-116870 Apr 2003 JP
2003-126110 May 2003 JP
2003-310627 May 2003 JP
2003-530921 Oct 2003 JP
2003-339730 Dec 2003 JP
2004-147701 May 2004 JP
2005027026 Jan 2005 JP
2005-040222 Feb 2005 JP
2005-066316 Mar 2005 JP
2005-074088 Mar 2005 JP
2005-534451 Nov 2005 JP
2006-6410 Jan 2006 JP
2006-512149 Apr 2006 JP
2006-116194 May 2006 JP
2006-158525 Jun 2006 JP
2006-218296 Aug 2006 JP
2006217716 Aug 2006 JP
2006-288431 Oct 2006 JP
2007-050181 Mar 2007 JP
2003-126104 May 2007 JP
2007-229454 Sep 2007 JP
2007-527747 Oct 2007 JP
2008-508065 Mar 2008 JP
2008-119250 May 2008 JP
2008-521503 Jun 2008 JP
2008-212679 Sep 2008 JP
2008-536562 Sep 2008 JP
2008-284374 Nov 2008 JP
2009-511206 Mar 2009 JP
2009-517181 Apr 2009 JP
4262923 May 2009 JP
2009-523567 Jun 2009 JP
2009-236177 Oct 2009 JP
2009-254819 Nov 2009 JP
2010-000336 Jan 2010 JP
2010-514923 May 2010 JP
2010-534522 Nov 2010 JP
2010-540186 Dec 2010 JP
2011-505198 Feb 2011 JP
2012-235658 Nov 2012 JP
2154437 Aug 2000 RU
WO 9222259 Dec 1992 WO
WO 9308757 May 1993 WO
WO 9314708 Aug 1993 WO
WO 9316646 Sep 1993 WO
WO 9320877 Oct 1993 WO
WO 9421183 Sep 1994 WO
WO 9424949 Nov 1994 WO
WO 9509572 Apr 1995 WO
WO 9534259 Dec 1995 WO
WO 9630885 Oct 1996 WO
WO 9639086 Dec 1996 WO
WO 9816156 Apr 1998 WO
WO 9826739 Jun 1998 WO
WO 9835621 Aug 1998 WO
WO 9837815 Sep 1998 WO
WO 9920213 Apr 1999 WO
WO 9952489 Oct 1999 WO
WO 0064358 Nov 2000 WO
WO 0074585 Dec 2000 WO
WO 0124713 Apr 2001 WO
WO 0154590 Aug 2001 WO
WO 0167970 Sep 2001 WO
WO 0195810 Dec 2001 WO
WO 0224080 Mar 2002 WO
WO 0238057 May 2002 WO
WO 02062241 Aug 2002 WO
WO 03082133 Oct 2003 WO
WO 2004012615 Feb 2004 WO
WO 2004026104 Apr 2004 WO
WO 2004032754 Apr 2004 WO
WO 2004032762 Apr 2004 WO
WO 2004032763 Apr 2004 WO
WO 2004037095 May 2004 WO
WO 2004098426 Nov 2004 WO
WO 2004112618 Dec 2004 WO
WO 2005122917 Dec 2005 WO
WO 2006012797 Feb 2006 WO
WO 2006042210 Apr 2006 WO
WO 2006058223 Jun 2006 WO
WO 2006063199 Jun 2006 WO
WO 2006083988 Aug 2006 WO
WO 2006101661 Sep 2006 WO
WO 2006119139 Nov 2006 WO
WO 2006119376 Nov 2006 WO
WO 2006129465 Dec 2006 WO
WO 2007008703 Jan 2007 WO
WO 2007008710 Jan 2007 WO
WO 2007038538 Apr 2007 WO
WO 2007040818 Apr 2007 WO
WO 2007047380 Apr 2007 WO
WO 2007047531 Apr 2007 WO
WO 2007056590 May 2007 WO
WO 2007087272 Aug 2007 WO
WO 2007143665 Dec 2007 WO
WO 2008016886 Feb 2008 WO
WO 2008042021 Apr 2008 WO
WO 2008049084 Apr 2008 WO
WO 2008051764 May 2008 WO
WO 2008089174 Jul 2008 WO
WO 2008118709 Oct 2008 WO
WO 2008130793 Oct 2008 WO
WO 2009010565 Jan 2009 WO
WO 2009018067 Feb 2009 WO
WO 2009018406 Feb 2009 WO
WO 2009027065 Mar 2009 WO
WO 2009046234 Apr 2009 WO
WO 2009073402 Jun 2009 WO
WO 2009120992 Oct 2009 WO
WO 2010068783 Jun 2010 WO
WO 2011008672 Jan 2011 WO
WO 2011052939 May 2011 WO
WO 2011100321 Aug 2011 WO
WO 2011144911 Nov 2011 WO
WO 2012061722 May 2012 WO
WO 2012128362 Sep 2012 WO
WO 2012135705 Oct 2012 WO
WO 2012135721 Oct 2012 WO
WO 2013018934 Feb 2013 WO
WO 2013062978 May 2013 WO
Non-Patent Literature Citations (32)
Entry
International Search Report for PCT/US2008/070983, Nov. 7, 2008 (5 pages).
Extended European Search Report for 08782303.5, dated Jun. 9, 2015 (8 pages).
Technology Overview, printed from www.harmonicscalpel.com, Internet site, website accessed on Jun. 13, 2007, (3 pages).
Sherrit et al., “Novel Horn Designs for Ultrasonic/Sonic Cleaning Welding, Soldering, Cutting and Drilling,” Proc. SPIE Smart Structures Conference, vol. 4701, Paper No. 34, San Diego, CA, pp. 353-360, Mar. 2002.
AST Products, Inc., “Principles of Video Contact Angle Analysis,” 20 pages, (2006).
Lim et al., “A Review of Mechanism Used in Laparoscopic Surgical Instruments,” Mechanism and Machine Theory, vol. 38, pp. 1133-1147, (2003).
Graff, K.F., “Elastic Wave Propagation in a Curved Sonic Transmission Line,” IEEE Transactions on Sonics and Ultrasonics, SU-17(1), 1-6 (1970).
Makarov, S. N., Ochmann, M., Desinger, K., “The longitudinal vibration response of a curved fiber used for laser ultrasound surgical therapy,” Journal of the Acoustical Society of America 102, 1191-1199 (1997).
Morley, L. S. D., “Elastic Waves in a Naturally Curved Rod,” Quarterly Journal of Mechanics and Applied Mathematics, 14: 155-172 (1961).
Walsh, S. J., White, R. G., “Vibrational Power Transmission in Curved Beams,” Journal of Sound and Vibration, 233(3), 455-488 (2000).
Gooch et al., “Recommended Infection-Control Practices for Dentistry, 1993,” Published: May 28, 1993; [retrieved on Aug. 23, 2008]. Retrieved from the internet: URL: http//wonder.cdc.gov/wonder/prevguid/p0000191/p0000191.asp (15 pages).
Huston et al., “Magnetic and Magnetostrictive Properties of Cube Textured Nickel for Magnetostrictive Transducer Applications,” IEEE Transactions on Magnetics, vol. 9(4), pp. 636-640 (Dec. 1973).
Incropera et al., “Fundamentals of Heat and Mass Transfer”, Wiley, New York (1990). (Book—not attached).
F. A. Duck, “Optical Properties of Tissue Including Ultraviolet and Infrared Radiation,” pp. 43-71 in Physical Properties of Tissue (1990).
Orr et al., “Overview of Bioheat Transfer,” pp. 367-384 in Optical-Thermal Response of Laser-Irradiated Tissue, A. J. Welch and M. J. C. van Gemert, eds., Plenum, New York (1995).
Campbell et al, “Thermal Imaging in Surgery,” p. 19-3, in Medical Infrared Imaging, N. A. Diakides and J. D. Bronzino, Eds. (2008).
Sullivan, “Cost-Constrained Selection of Strand Diameter and Number in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 16, No. 2, Mar. 2001, pp. 281-288.
Sullivan, “Optimal Choice for Number of Strands in a Litz-Wire Transformer Winding,” IEEE Transactions on Power Electronics, vol. 14, No. 2, Mar. 1999, pp. 283-291.
http://www.apicalinstr.com/generators.htm.
http://www.dotmed.com/listing/electrosurical-unit/ethicon/ultracision-g110-/1466724.
http:/www.ethicon.com/gb-en/healthcare-professionals/products/energy-devices/capital//ge . . . .
http://www.4-traders.com/Johnson-Johnson-4832/news/Johnson-Johnson-Ethicon-E . . . .
http://www.medicalexpo.com/medical-manufacturer/electrosurgical-generator-6951.html.
http://www.megadyne.com/es—generator.php.
http://www.valleylab.com/product/es/generators/index.html.
Covidien 501(k) Summary Sonicision, dated Feb. 24, 2011 (7 pages).
Gerhard, Glen C., “Surgical Electrotechnology: Quo Vadis?,” Biomedical Engineering, IEEE Transactions on , vol. BME-31, No. 12, pp. 787, 792, Dec. 1984.
Fowler, K.R., “A programmable, arbitrary waveform electrosurgical device,” Engineering in Medicine and Biology Society, 1988. Proceedings of the Annual International Conference of the IEEE, vol., No., pp. 1324, 1325 vol. 3, Nov. 4-7, 1988.
LaCourse, J.R.; Vogt, M.C.; Miller, W.T., III; Selikowitz, S.M., “Spectral analysis interpretation of electro-surgical generator nerve and muscle stimulation,” Biomedical Engineering, IEEE Transactions on , vol. 35, No. 7, pp. 505, 509, Jul. 1988.
U.S. Appl. No. 13/751,680, filed Jan. 28, 2013.
U.S. Appl. No. 14/827,764, filed Aug. 17, 2015.
European Examination Report for 08782303.5, dated Jun. 2, 2016 (4 pages).
Related Publications (1)
Number Date Country
20150066067 A1 Mar 2015 US
Divisions (1)
Number Date Country
Parent 11881645 Jul 2007 US
Child 14537815 US